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Abstract
The bacterial flagellum is made up of approximately 20,000 subunits of the monomeric
protein, flagellin, and plays a role in cell motility and pathogenesis. The extreme se-
quence diversity within the hypervariable region of flagellin genes observed across phyla
suggests hidden functional diversity. This thesis outlines the discovery of the first fam-
ily of flagellin variants with proteolytic activity. A multi-faceted approach revealed a
conserved HExxH motif within the hypervariable region (HVR) of these flagellin vari-
ants. The motif is characteristic of the Gluzincin family of thermolysin-like peptidases
and was found to be conserved in 74 bacterial species spanning over 32 genera. Exper-
imental validation began with the recombinant expression and purification of the HVR
of the flagellin FliA(H) from the species Clostridium haemolyticum, an animal pathogen.
An approach using mass spectrometry and proteomics revealed that the substrate speci-
ficity of this flagellin protease is similar to that of zinc-dependant matrix metallopepti-
dases (MMPs). Furthermore, peptide sequencing of harvested C.haemolyticum flagellar
filaments revealed that the proteolytic flagellin was the second most dominant flagellin
component and was also shown to have MMP-like protease activity. Considering the ex-
panded functional repertoire of this organelle in the recent years, this flagellin-associated
protease may play a role in chemotaxis, biofilm formation, adhesion and pathogenesis.
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Chapter 1
Introduction
1.1 The bacterial flagellum
The bacterial flagellum is a remarkable self-assembling molecular nanomachine. Histori-
cally, its function has primarily been associated with locomotion, however recent studies
have expanded its functional repertoire [1, 2]. The flagellum is now known to be actively
interacting with the environment. The flagellum is involved in pathogenesis, chemotaxis
as well as has antigenic properties. The bacterial flagellum is a highly complex organelle.
Approximately 40 genes are involved in the expression and regulation of the flagellum
out of which approximately 24 are structural proteins [3].
1.1.1 Structure
The structure and arrangement of the flagellum varies greatly between flagellated species.
Structural diversity is also mirrored at the sequence level. The overall structure of the
bacterial flagellum has been elucidated based on structural studies on Escherichia coli
and Salmonella enterica serovar Typhimurium. As shown in Figure 1.4, the bacterial
flagellum consist of three parts which include the basal body, hook and the filament [4].
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Figure 1.1: Structure of the bacterial flagellum based on Salmonella enterica
serovar Typhimurium
The figure represents components of an assembled bacterial flagella based on
Salmonella enterica serovar Typhimurium. The It consists of the basal body
and hook which span the cell wall and membranes, and a flagellar filament
that protrudes outwards. This figure was adapted from [4] with permission.
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Basal Body
The basal body acts as the engine that allows for the generation of torque and thereby
the rotation of the flagellar filament. The basal body is a multi-unit component and
is located within the cytoplasmic membrane. The basal body consists of several rings
mounted onto a central rod (further divided into proximal and distal rods) and a motor
which can be further subdivided into rotor and stator complexes. The rings include an
inner-membrane embedded MS ring (proximal end of the basal body), a P ring which is
attached to the peptidoglycan layer and an outer-membrane embedded L ring [5].
The rotor or switch complex is composed of the proteins FliG, FliM and FliN [3] that
assemble together to form the cytoplasmic-facing C ring. These rotor proteins inter-
act with the phosphorylated subunit of the regulatory protein CheY (part of the two-
component chemosensory system) to allow the motor to alternate between clockwise and
counterclockwise directions [4]. This is how the organelle responds to chemical changes
and thus allowing bacteria to move towards favourable environments (chemotaxis), as
well as near-surface swimming and mechanosensing. The stator complexes, in contrast
to the rotor, are stationary. Two cytoplasmic-membrane spanning proteins, MotA and
MotB, which appear in a ratio of 4:2, form the stator complex [4] [6]. MotA and MotB
proteins tend to be arranged in a circular array around the MS and C rings [6] with the
periplasmic domain of MotB attached to the peptidoglycan layer [4].The stator is an ion-
channel capable of harvesting electrochemical energy generated from the proton motive
force (or sodium motive force in some species) and generate torque via the rotor com-
plex.
Hook
The hook is a short, curved structure which connects the filament to the basal body.
The hook is primarily composed of 120 copies of the protein FlgE that polymerize to
form a helical tube consisting of 11 protofilaments [7, 8]. The hook tends to act as a uni-
versal joint that transmits torque from the cell-membrane embedded motor and transfers
it to the outwardly protruding filament [7]. The hook is a highly flexible structure and
thus allows organisms to maneuver their rigid flagellar filaments without breaking them
off the cell e.g. the flexibility conferred by the hook allows petrichious flagella in vari-
ous organisms to function properly as a bundle [4]. The hook extends to 55 nm on aver-
age, but the length can vary depending on the assembled structure [9].The length of the
hook is controlled by the protein FliK during flagellar assembly [7]. The hook has a 25 A˚
channel running through the centre[9].
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Filament
The filament is an appendage that protrudes from the cell body and acts as a helical
propellor that allows for the propulsion of cells. The number and arrangement of flag-
ella differ between bacterial species, for example they may be polar (Pseudoalteromonas
tunicata), lateral (Aeromonas spp.), peritrichous (Escherichia coli, Salmonella spp.), am-
phitrichious or periplasmic (Spirochaetes). The flagellar filament is a protein complex
composed of 11 protofilaments which are in turn composed of approximately 20,000 sub-
units of the monomeric structural protein, flagellin (FliC)[10]. The protofilaments are
axially staggered relative to the central axis by approximately half a subunit [2]. These
flagellin protein subunits self-assemble to form a hollow tube which is, on average, 20 nm
wide [11] and extends up to 10 - 15 µm long [1].
Depending on the arrangement of subunits within the protofilaments, they may form a
right or left-handed helix i.e. R or L-type[2]. The R-type refers to short protofilaments
in which the subunits are closer together. The L-type, on the other hand, refers to long
protofilaments in which the subunits are further apart. Depending on the ratio of the
type of protofilaments present at any given time, can result in 12 different conformations
of the filament i.e. if both R and L-type protofilaments are present, the filament will be
helical which can occur in 10 different ways, if all protofilaments are L-type, the filament
will be long and if they are all R-type, the filament will be short [6]. Bacteria exhibit-
ing different forms of motility (e.g. run and tumble) can do so via the flagellar filament
switching between right and left-handed supercoiled forms. These forms, in turn are
produced by the alternation between the L and R type protofilaments explained above
[12]. Like any proteins, flagellar filaments take different polymorphic forms based on the
amino acids in their respective flagellins as well as the pH of the surrounding environ-
ment [8].
The sequences of these flagellin proteins display an interesting pattern. Each flagellin
protein tends to have slowly evolving N- and C-terminal regions (corresponding to D0
and D1 domains in Salmonella typhimurium) that form the core of the assembled fila-
ment, however the central/intervening region, called the hypervariable region or HVR, is
highly variable in sequence and length within and between species. The HVR forms the
surface-exposed region in the assembled appendage [13]. Each flagellin molecule takes
an inverted gamma conformation with the vertical arm being the N- and C-termini and
the horizontal arm being the surface-exposed HVR [2]. The N- and C-termini tend to be
rich in hydrophobic residues which allows the domains to be coiled-coil [2], [13]. Several
hypotheses exist to explain the dual sequence diversity and conservation of flagellin se-
quences within and between various bacterial species. Since the N- and C-termini tend
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to be important for the structural integrity of the assembled flagella, they remain con-
served. The surface-exposed region, however, interacts with the environment e.g. it has
antigenic properties, it tends to be under positive selection [2]. Another factor driving
the variability of the HVR is due to lateral gene transfer of foreign genes as well as re-
combination [14].
1.1.2 Assembly
Escherichia coli and Salmonella spp. are primary models for studying flagellar structure
and assembly. More than 40 genes are involved in the regulation and assembly of a flag-
ellum with approximately 24 being structural proteins [3]. The assembly process tends
to be linear/sequential and starts from the innermost (proximal) to the outermost (dis-
tal) structures. To recap, the flagellar apparatus consists of the multi-component basal
body, the flexible hook and the flagellar filament. To understand the assembly, it is also
important to remember that the cell envelope of bacteria include an inner cytoplasmic
membrane, a thick or thin peptidoglycan layer (depending on whether they are Gram-
negative or Gram-positive) and an LPS-rich outer-membrane in Gram-negative bacteria.
MS ring
The assembly of the basal body (and therefore, the entire flagellar complex) begins with
the MS ring [4]. The assembly of the MS ring is dependent on the Sec export mecha-
nism.The MS ring complex is composed of approximately 26 copies of a single monomeric
protein, FliF. These monomers assemble into a single ring structure that appear as two
adjacent loops consisting of various sub-structures.The entire MS ring complex spans the
cytoplasmic membrane[9]. Once the assembly of the MS ring is completed, assembly of
flagellar apparatus occurs inwards, outwards and laterally [15].
C-ring/Rotor/Switch complex
The inward assembly starts with the switch complex/C-ring. This complex is composed
of three proteins: FliG, FliM and FliN. Once FliG binds to the cytoplasmic face of the
MS-ring, the proteins FliM and FliN are recruited. FliM acts as an intermediate between
FliG and FliN. The N-terminus of FliM interacts with the phosphorylated subunit of
CheY, the middle domain interacts with FliG and the C-terminus interacts with FliN.
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The N-terminus and the middle region are involved with rotational switching and the C-
terminus is involved in flagellar assembly. The C-ring is the only structure that is com-
pletely embedded within the cytoplasmic membrane of bacteria [9].
Flagellar Type Three Secretion System
The Flagellar Type Three Secretion System or fTTSS apparatus is homologous to the
apparatus responsible for the export of virulence factors in pathogenic bacteria [15]. The
fTTSS assembles within the C-ring.
Stator
The lateral assembly of the flagellar apparatus involves the assembly of the stator. The
Stator is composed of two proteins MotA and MotB that together form the ion channel
through the plasma membrane. These proteins assemble in a ring structure consisting of
10 studs with the periplasmic domain of MotB attached to the peptidoglycan layer [15]
[3]. The stator is assembled around the rotor after the hook-basal body (HBB) structure
is completed [16]. As mentioned before, the stator is responsible for torque generation.
Rod
The rod is a helical tube with a coiled-coil conformation. It can be divided into two dis-
tinct units i.e. proximal and distal. The distal component of the rod is composed of the
protein FlgG and FliE. The proximal rod is formed by 6 subunits each of FlgB, FlgC
and FlgF [4] [9]. These proteins are exported across the cytoplasmic membrane by the
fTTSS and assemble in the periplasm [4].
P and L rings
The P ring is composed of 26 FlgL monomers that assemble around the rod. The P-
ring connects to the peptidoglycan cell wall. The L ring is composed of 28 monomers
of FlgH and connects to the outer-membrane. It is known that the C-terminus of FliT is
essential for the assembly of the L-ring. Together they form the homopolymeric P/L ring
complex that act as the rod bushing [4].
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Hook
The Hook is made of 120 copies of the monomer FlgE. Hook assembly is initiated when
the rod cap protein FlgJ is displaced by the hook-capping protein FlgD at the distal end.
Monomers of FlgE are exported across the cytoplasmic membrane by the fTTSS. These
protein subunits pass through the central channel and self-assemble endogenously from
base to tip. Once the hook reaches a certain length, the fTTSS undergoes a switch in
substrate specificity from early flagellar substrates to late flagellar substrates. This oc-
curs due to the fTTSS protein FlhB and mediated by the hook-length control protein
- FliK. The hook cap is then discarded and replaced with hook-associated proteins or
HAPs. This marks the end of the assembly of the HBB (Hook-Basal body complex).
Filament
HAPs are the monomeric proteins: FliD, FlgL and FlgK. Before the assembly of the fil-
ament begins, the HAPs momentarily form a complex at the distal end. These are the
first filament-type substrates to be transported by the fTTSS. FliD is a pentagonal disc
that forms the filament cap, whereas FlgL and FlgK form the hook-filament junction [9],
[15]. The filament is composed of approximately 20,000 subunits of the monomeric pro-
tein flagellin (FliC). These protein subunits travel the entire length of the central chan-
nel until they assemble at the distal end of the growing filament.
1.1.3 Regulation
Flagellar gene networks are highly complex and are responsible for the expression of over
40 structural and regulatory genes [17]. Synthesis of structural genes for assembly of a
bacterial flagella occurs sequentially with gene products being transcribed as they are
needed during assembly. Temporal regulation of flagellar genes is highly complex and co-
ordinated. It occurs via networks that employ checkpoints within the flagellar expression
pathway. Overall, the process begins with the expression of class I genes which encode a
master regulator that triggers the hierarchal expression of class II genes (i.e. structural
and regulatory genes) [18].
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1.2 Function of flagella in the environment
As mentioned above, the bacterial flagellum is an organelle responsible for locomotion.
Flagellum-mediated motility is coupled with chemoreceptor systems, allowing bacterial
species to sense and move towards favourable environments. For pathogenic bacteria,
these environments may be sites of infection thus assisting flagellated microbes to move
towards hosts and/or target sites during infection. The flagellum can secrete virulence
factors, aid in biofilm formation and have adhesive properties [1]. Flagella also tend to
be antigenic and can be detected by the human immune system.
1.2.1 Motility
The primary function of the bacterial flagellum is locomotion. The two types of flagellar-
mediated motility adopted by microorganisms include swimming and swarming.
Swimming refers to the movement of individual bacterial cells within a liquid (though
sometimes, it may also occur on top of a surface). Bacteria such as Escherichia coli swim
by executing run and tumble processes. When Escherichia coli moves in a series of smooth
straight paths, the movement is referred to as a run. A tumble on the other hand, is
characterized as a sudden turn/reversal that results in a random re-orientation of the
bacterial cell. After a tumble, the bacterial cell will resume a run in the new direction.
Chemotactic bacteria alter their frequency of tumbles when moving towards attractants
or moving away from repellents. For example, the frequency of tumbles will be reduced
to extend each run when moving towards a favourable environment. This kind of move-
ment is also referred to as a directed random walk [19]. The run or tumble is a result
of changing rotational directions of the flagellar rotor as well as polymorphic transitions
of protofilaments within the filament. For a run, the rotor rotates in a CCW direction
and the protofilaments transition to a left-handed helix bundle. On the other hand, for a
tumble to occur, the rotor rotates CW and the protofilaments adopt a right-handed con-
formation [1]. Details about the different protofilament conformations have been outlined
under section (filament). It is also important to note that not all filaments need to be
in a bundle to cause a run, in fact only one or two need to change rotation to CW and
cause a tumble (tumble varies depending on ratio of CW-rotating flagella and duration
of CW rotation) [20].
Swarming refers to the movement of a group of bacterial cells on a surface and/or through
viscous liquids. Swarming motility can have different phenotypes and is also inducible.
There is a correlation between bacteria that have peritrichous flagella and swarming
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motility. This is because petrichious flagella bundle together when rotated by the motor
which results in increased flagellar stiffness and therefore a greater propulsive force al-
lowing bacteria to move within viscous fluids [21]. It is important to note that bacterial
species such as Rhodosprillum centenum and Aeromonas spp. have a single polar flagel-
lum and can selectively induce expression of petrichious flagella to swarm. Since polar
and lateral flagella are controlled by different motors and also expressed through differ-
ent genes, the pathogenic bacterium, Pseudomonas aeruginosa, unlike other species, re-
tains its polar flagella but synthesizes an alternative motor to allow for swarming motil-
ity [21].
1.2.2 Pathogenesis
The bacterial flagellum plays an important role in various aspects of pathogenesis. The
pathogenic cycle can be divided into four parts 1) reaching the host/target site, 2) colo-
nization or invasion, 3) growth and maintenance and 4) dispersal to new host or target
sites (Figure 1.2) [22]. How the flagellum plays a role in each of these parts will be dis-
cussed in detail.
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Figure 1.2: Role of bacterial flagella in pathogenesis
The figure represents the role of bacterial flagella in 4 stages of pathogenesis.
Flagellar mediated motility and chemotaxis is used to disperse to favourable
environments or find host sites. Role of flagella in biofilm formation as well
as the secretion of virulence factors by the flagellar type three secretion
system allows bacterial cells to colonize hosts. Further evasion of host
immune system is done by modifying expression of flagellar genes as well as
antigenic variation and post-translational modification. This figure is based
on [22].
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Reaching the host/target site
The first task of a pathogenic bacteria is to find the target site and move towards it.
Chemotaxis is the process by which bacteria actively sense their environment and move
towards favourable sites. The interaction between chemotaxis and flagellar motility al-
lows the bacteria to have a directed trajectory towards a host as opposed to depending
on Brownian motion. As mentioned in section 1.1.1, the phosphorylated subunit of the
signalling protein, CheY interacts with the flagellar rotor and thereby controls it’s di-
rection of rotation. In Escherichia coli , high amounts of phosphorylated CheY results
in frequent tumbling and low amounts lead to more runs. Pathogenic bacteria tend to
have chemoreceptor proteins in their flagellum which have evolved to control the amount
of phosphorylated CheY proteins depending on their environment [22]. Examples of
pathogenic organisms that utilize chemotaxis to move selectively towards target sites,
include, Salmonella spp. which colonize the intestinal epithelium, C.jejuni, which colo-
nize zones in intestines which are rich in mucin/glycoproteins, and many others. Stim-
uli other than chemicals are also known to be important for directing the movement of
pathogenic bacteria [22].
Many pathogens can sense their environment via regulatory systems other than chemo-
taxis. Upon sensing the environment, these pathogenic bacteria can enhance their motil-
ity through flagellar regulation. For example, Enterohemorrhagic Escherichia coli needs
to penetrate the polysaccharide and glycoprotein rich mammalian intestinal surface,
before being able to colonize the epithelial cell surfaces. EHEC can detect short chain
fatty acids in the large intestine upon which they can trigger their motility. The detec-
tion of fatty acids however, does not occur through chemotaxis, but instead through two
transcriptional regulatory steps for flagellar biosynthesis. Another example of alternate
flagellar-driven motility is Vibrio cholera which detects high bile levels through a two-
component regulatory system and in turn increases motility [22].
Flagellated bacterial pathogens also use near-surface swimming to find entry sites for in-
fection and colonize hosts more efficiently. Near-surface swimming is a phenomenon in
which bacteria are entrapped at surfaces thus swimming due to physical and hydrody-
namic forces. This allows flagellated organisms to search for receptors or entry sites on
a 2D plane as opposed to a complex 3D plane [22]. Salmonella Typhimurium is a flagel-
lated pathogen that adheres to a host intestinal surface and triggers formation of mem-
brane ruﬄes. Multiple bacteria tend to invade by entering through the same ruﬄe. It
has been shown in vitro that these bacteria reach the target site by non-chemotaxis flag-
ellar motility and are subsequently trapped on the surface (near-surface swimming) that
increases the pathogen density and makes the scanning of the host topology more effi-
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cient. Together this allows the pathogens to efficiently enter through the same route [23].
Pathogenic bacteria need to recognize when they arrive at an optimal target site and
then trigger colonization. The bacterial flagellum acts as a mechanical sensor that can
allow bacteria to do this. For example, in members of the alpha and gamma proteobac-
teria, bacterial flagella can initiate differentiation into swarmer cells and therefore start
pathogenesis. Finally, the bacterial flagellum, can also trigger biofilm formation at target
site in bacteria such as Pseudomonas aeruginosa and V. cholera. Flagellar stators tend
to be the primary organelles responsible for mechano-sensing for biofilm formation [22].
Flagellar-mediated motility is important for detection and subsequent colonization of
hosts. This has been shown by various examples. For example, it has been shown that
non-motile, flagella-less mutants of Pseudomonas fluorescens show reduced colonization
of their host, potato roots [24]. Campylobacter jejuni is another organism where non-
motile mutant strains show reduced colonization of the intestine [25].
Colonization or invasion
After reaching the site of infection, the flagellum continues to assist the pathogen by be-
ing directly or indirectly involved in the subsequent progression of infection. There are
multiple ways in which this may happen and these will be reviewed in this section.
Adherence to a surface is an essential step in the invasion of a host. Adhesive proper-
ties of flagellins assists in adhering to target surfaces via bacterial filament. Flagellin is
known to act as an adherence molecule in various Escherichia colistrains. In enteropathogenic
Escherichia coli (EPEC), flagellin’s adhesive capabilities assist them in epithelial cell in-
vasion and in Escherichia coli O157:H7, flagellin allows for interaction with the bovine
intestinal epithelium. It has also been shown that fliC deletion mutants in EPEC and
EHEC show reduced binding to host proteins such as mucin from bovine mucus [26].
Pseudomonas aeruginosa is another pathogen that uses both flagellin and flagellin cap
protein (FliD) as adhesin molecules that allow it to adhere to mucin. Pseudomonas aerug-
inosa has also been known to use FliF (MS-ring) for adhering to mucin [22]. Adhesive
properties of flagella have also been demonstrated in Clostridium difficile in which ad-
herence of crude flagella, FliC and FliD to axenic mouse cecal mucus in vitro was shown
[27].
Pathogenic bacteria also tend to establish biofilms after successfully identifying and reach-
ing an infection site. Biofilms are formed when multiple bacteria adhere to a surface
and differentiate into aggregates (single or multiple species) encased within an EPS-
rich matrix [28]. For a flagellated bacterial cell to transition from free-swimming to a
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biofilm lifestyle, it must slow down by inhibiting it’s flagellar rotation. In Bacillus sub-
tilis, cyclic di-GMP acts as the control protein which controls flagellar rotation by inter-
fering with FliG(C-ring) and MotA(stator) interaction. Similarly, in gram-negative bac-
teria such as Escherichia coli and Salmonella, cyclic di-GMP acts as a messenger protein
enabling control of the flagellar motor [22]. Overall, flagellar motility as well as the flag-
ellar molecule itself are important for the initial adherence of the bacterium to the sur-
face as well as the subsequent differentiation into biofilms for a successful invasion of the
host. It is important to note that the flagella assist non-pathogenic bacteria in surface
colonization by forming biofilms as well. An example is Pseudoalteromonas tunicata, a
marine bacterium, which is known for its ability to form biofilms. This bacterium tends
to compete with the epiphytic bacterial community associated with eukaryotic surfaces
to form biofilms [29, 28, 30].
Another important role of the flagellum in colonization is through secretion of virulence
factors via the fTTSS or the flagellar export apparatus. Mechanistic insights into the
role of fTTSS in virulence have been gained from sequence and structural similarities
shared between the the non-flagellar TTSS and the flagellar export apparatus [31]. Non-
flagellar TTS is a structure used by Gram-negative bacteria to translocate virulence
proteins directly into the cytosol of their respective eukaryotic hosts. TTSS containing
pathogens tend to cause a diverse number of diseases. Some of these pathogens include
Salmonella, Escherichia coli (EPEC and EHEC), and Pseudomonas aeruginosa [32].
Phylogenetic analysis has indicated that the bacterial TTSS has evolved from an ances-
tral bacterial flagellum thus suggesting parallels in the flagellum’s involvement in patho-
genesis [22].
Growth, maintenance and dispersal
Once a pathogen has entered its host and established an infection, it enters a growth
stage. To replicate within the host, it needs to evade the immune system in place to rec-
ognize and destroy these pathogens. Eukaryotic hosts such as mammals have pattern
recognition receptors or PRRs that have evolved to recognize conserved components of
microbial pathogens. These components are called pathogen-associated molecular pat-
terns or PAMPs. Since flagellin proteins have conserved N- and C- termini imperative to
assembly of the filament, they become ideal PAMPs. It has, however, also been shown,
however, that deletions in the central region of flagellin in Escherichia coli K-12 strains
also has a direct effect on H-antigenicity (a flagellum-specific bacterial antigen) [33].
Hosts other than mammals, use Toll-like receptors or TLRs to recognize PAMPs [34].
TLR5 primarily recognizes bacterial flagellins. Considering how the bacterial flagella has
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antigenic properties, flagellated species evade the immune system by various methods.
These include reducing or eliminating flagellar expression, phase variation which refers to
the alternate expression of flagellar proteins and varying the proportion of bacteria that
express flagella. Other evasion strategies include ways in which the bacterial flagellin is
unrecognizable to TLR5; i.e. post-translational modifications such as glycosylation of
flagellins and slightly altering the core sequence of flagellins, for example, mutations in
the conserved N-terminus [22].
Lastly, at the end of the pathogenic cycle, bacteria need to escape their hosts and dis-
perse. These bacteria use flagellar-mediated motility to leave the site of infection, and
move towards new favourable environments [22].
1.3 Engineering and modularity of the bacterial flag-
ellum
Self-polymerizing flagellin monomers are highly modular and are being utilized for ge-
netic engineering. For example, the hypervariable domain (D3) of Salmonella FliC is a
good target for the construction of a GFP (green fluorescent protein) fusion which subse-
quently results in a fluorescent filament[35]. As mentioned in 1.1.1, the conserved N- and
C- termini of flagellins are responsible for polymerization and therefore extensive mod-
ification of the HVR does not affect self-assembly of the flagellar filament. Engineering
HVRs of flagellins to construct protein fusions would result in up to 20,000 such HVRs
simultaneously expressing the target proteins thus optimizing recombinant protein ex-
pression. Modularity of the bacterial flagellum is also utilized for bacterial surface dis-
play techniques in various facets of protein expression as well as screening and analysis of
large protein libraries [36, 37].
1.4 Zinc-dependent metalloproteases
1.4.1 Background
Metalloproteases or MPs are a group of proteolytic enzymes that require a divalent metal
ion for catalysis. They are responsible for the cleavage of peptide bonds and play a role
in various physiological processes [38, 39].
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Classification of MPs based on the MEROPS database is one of the most comprehen-
sive and is also broadly accepted. The MEROPS database uses sequence similarity and
evolutionary distance to classify proteases into families, which are then grouped into
clans based on homology. The classification is made more robust with three-dimensional
structural data of proteases when available [38, 40]. MPs can be mono or di-metalate.
Dimetalate MPs are usually exopeptidases [38] and include proteases such as the ami-
dohydrolase superfamily [41]. Monometalate or mononuclear MPs are divided into dif-
ferent tribes including, inverzincins, zincins, HybD, LAS MPs and αβα-exopeptidases,
with the two main ones being Metzincins and Gluzincins. The names reflect their loop
structures: i.e. Met-turn and Ser/Gly turn in the C-terminus subdomain respectively.
Zinc-dependent MPs have a common domain structure. This consists of a signal peptide,
a propeptide and a catalytic domain [42].
Most monometallic MPs belong to the zincin tribe that have more than 100 coding genes
in humans [38]. Most of these MPs require a divalent metal ion Zn2+, and sometimes
cobalt for activity. The zincin tribe is characterized by the catalytic HExxH motif. This
motif consists of two zinc-binding histidine residues and a glutamate that performs gen-
eral base catalysis by providing the nucleophile for cleavage of peptide bonds. The gen-
eral reaction catalyzed by these MPs includes a single step in which the glutamate acts
as a general acid/base that is responsible for activating a zinc-bound H2O molecule.
This provides the nucleophile for cleaving peptide bonds without a covalent intermedi-
ate. These reactions follow Michaelis-Menten kinetics at neutral pH [43, 38]. This mech-
anism was derived from research on the thermolysin from Bacillus thermoproteolyticus
and bovine carbopeptidase A [44, 45, 46, 38].
A general mechanism for peptide-bond hydrolysis by MPs has been elucidated with struc-
tural data (X-ray crystallography) and structural modelling. Based on work by Schechter
and Berger on the endopeptidase, papain and its substrate, alanine peptides, It has been
shown that the substrate tends to bind the active site in an extended conformation [47].
The active site cleft itself is also in an “optimal” conformation prior to catalysis and
is therefore accessible to the peptidic substrate [47]. The active site cleft has been di-
vided into two parts with respect to the scissile peptide bond. The part upstream the
active site cleft is termed as the N-terminal upstream region and the part below as the
C-terminus downstream region. The upstream region is annotated to be “non-prime”
and the downstream region as “prime” [47, 38].
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Figure 1.3: Overview of zincin family metalloprotease structure
(A) Metalloproteases belonging to the zincin tribe have the consensus catalytic
motif HExxH. The two histidines are responsible for binding zinc whereas, the
glutamate acts as a general base and and activates a catalytic solvent molecule to
provide nucleophile for the cleavage of peptide bonds. (B) The zincin tribe is
divided into gluzincin and metzincin. The gluzincin family of proteases contain an
additional downstream glutamate (33 to 35 aa downstream) within their peptidase
domains. The domain architecture is shown for ColG, a microbial collagenase from
Clostridium histolyticum.The metzincin family of proteases contain an additional
methionine in the C-terminus peptidase subdomain. The domain architecture is
shown for MMP-9 or gelatinase B.
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1.4.2 Gluzincins
The gluzincin superfamily of MPs forms one of the clans of the zincin tribe. Gluzincins
are distinguished from other MPs due to a characteristic Ser/Gly turn as well as a glu-
tamate which acts as the third metal binding residue. The Gluzincin clan has follow-
ing consensus sequence - HExxH. Additionally another motif [E/H]XXZ is found 33 -
35 amino acids downstream where X is any amino acid and Z is one of the following:
A/F/S/G/T [38] [48]. This clan is further divided into families including, bacterial col-
lagenases, clostridial neurotoxins, thermolysins and others.
Microbial collagenases
Microbial collagenases are MPs that belong to the MEROPS peptidase family M9 and
together are involved in the hydrolysis of different types of native collagen. Microbial
collagenases act as extracellular virulent factors and are known to be utilized by bacteria
for pathogenesis, and are implicated in human disease.
Collagen is the primary component of the ECM (extracellular matrix). Furthermore,
various types of collagens are also the most abundant proteins in animal tissues and
organs. Within the ECM, collagen fibres provide structural integrity and organization
whereas, collagen fibrils act as anchors for the attachment of macromolecules and other
cells. A collagen molecule is composed of three intertwined α chains that together form
a right-handed helix. Each α chain is composed of repeating units of Gly-X-Y, where X
and Y are any amino acids. These motifs are present in human collagens as well as some
prokaryotic collagens. Based on the structural differences, collagens are divided into two
major forms: fibrillar and non-fibrillar. Fibrillar collagen has a structure that is char-
acterized by undisturbed helices. It is comprised of more classic collagens i.e., type I, II
and III. Non-fibrillar collagens on the other hand contain non-helical regions interspersed
within the largely helical molecule. This category consists of type IV and VI collagens.
Type I collagen forms 95% of collagens within most animal tissue [49].
Clostridial collagenases were the first microbial collagenases to be biochemically char-
acterized and understood. These are large multi-domain proteins of approximately 115
kDa. The domain organization of clostridial collagenases has been identified through
structural studies on various existing isoforms of collagenases from different clostridia
species (ColG, ColH and ColT) [50, 51]. The basic structure consists of a collagenase
enzyme module and the recruitment domains. The collagenase module consists of a pre-
domain of variable length that contains the export signal and an N terminal domain (ac-
tivator and peptidase domains) that contains the catalytic zinc. The recruitment mod-
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ule consists of polycystic kidney disease-like (PKD-like) and collagen-binding (CBD) do-
mains. The number of each of these domains vary between collagenases [50, 51]. Bacte-
rial collagenases in contrast to vertebrate collagenases, can cleave collagen at multiple
sites and degrade it completely. Interestingly, clostridial collagenases have been shown
to require calcium along with zinc for catalytic activity [51]. The substrate specificity of
purified clostridial collagenases has confirmed preference for the characteristic collagen
motifs (Gly-Pro-X and Gly-X-Hyp, where X is any amino acid and Hyp is hydroxypro-
line) [52].
1.4.3 Metzincins
Metzincins form a clan belonging to the zincin tribe. This family consists of multi-domain,
zinc-dependent matrix metalloproteases (MMPs). This clan further subdivides into 12
distinct families out which of at least 7 have been structurally characterized. Each of
these families have distinct structural components. The domain architecture of met-
zincins includes an N terminal pro-domain, a protease domain consisting the follow-
ing consensus sequence, HExxHxxGxx[H/D] and a characteristic downstream Met-turn
[53]. Additionally, all MMPs except for MMP-7 and MMP-26 have a carboxyterminal
hemopexin domain [54].
MMP-9 or Gelatinase B
Matrix metalloproteases are principal mediators of extracellular matrix (ECM) mainte-
nance via remodelling and degradation. MMPs are also known for being essential players
in the host immune system. They are responsible for functions such as reduction of in-
flammation, killing of pathogens via effector cells and cleavage of cytokines. Irregular
activity of MMPs within the host is implicated in immunopathology [55].
MMP-9 (gelatinase B), has one of the most complex structures amongst the MMPs. In
addition to common structural features, MMP-9 contains an additional gelatin-binding
fibronectin domain as well as a Ser/Thr/Pro-rich collagen type V domain. Gelatinase B
is a heavily glycosylated protease and undergoes heterodimerization via disulfide bond-
ing. These factors complicate crystallization efforts [54, 56]. Though, gelatinase B with-
out the collagen and hemopexin domains has been crystallized, its catalytic domain has
been studied through crystallization of gelatinase A, an MMP which is the closest in se-
quence to gelatinase B [54].
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MMP-9 is an endoprotease whose substrate specificity depends on several factors. This
includes, within the catalytic site of the three-dimensional protein, availability of the
cleavage site on the substrate, primary sequence of the substrate and interestingly ex-
osites on the protein which interact with distal sites on the substrate and are impor-
tant for hydrolysis [54, 57]. Cleavage assays with synthetic peptides has revealed the pri-
mary sequence specificity of gelatinase B. A strong preference of hydrophobic residues at
the P1’ and P2 sites have been shown. This corresponds to the fact that the S1’ site of
MMPs contain a deep hydrophobic pocket. Preference for small amino acids such as Gly,
Ala and Pro has been shown at the P1 site. Physiological substrates of MMP-9 include
gelatin, which is a form of denatured collagens. Studies on gelatinase A have revealed
that the fibronectin domain is responsible for interacting with collagenous substrates.
Studies on type II gelatin, a primary substrate of gelatinase B has revealed that gelati-
nase B cleaves after a Gly residue at P1 position [54, 56].
1.5 Clostridium haemolyticum
Clostridium haemolyticum a.k.a Clostridium novyi type D is an anaerobic soil-borne
bacterium capable of forming spores. It is an animal pathogen responsible for causing
Bacillary hemoglobinuria or redwater disease in cattle [58]. It is ubiquitous in various
livestock-producing countries [59]. Clostridium novyi species are divided into types A,
B, C and D based on the type of toxin they produce. Types A and B are known to be
pathogenic and secrete types α and β toxins respectively, and type C is non-pathogenic.
Originally Clostridium haemolyticum was thought to be a member the type B species
due to biological similarities but phylogenetic analysis of several clostridia species by
16S rRNA sequencing has identified it as a separate species. The analysis revealed that
although Clostridium haemolyticum clusters with Clostridium botulinum type C and
D, it shares more than 99.9% sequence similarity with Clostridium novyi type B [60].
Clostridium haemolyticum was also considered to be a separate species due to its patho-
genesis not being related to alpha toxin production as is the case for types A and B. Fur-
thermore, the diseases caused by types A and B i.e., gas gangrene in animals/humans
and necrotic hepatitis in sheep respectively, are also different from Clostridium haemolyticum
which affects cattle [61].
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1.6 Computational predication of a novel proteolytic
flagellin family
As outlined in Section 1.1.1, bacterial flagellin sequences tend to have conserved N- and
C- termini that form the core of the assembled flagellar filament, however, their central
regions are highly variable and form the surface-exposed regions of the assembled fila-
ment (Figure 1.4). Given the sequence pattern displayed by the HVR as well as the in-
creasingly important role of flagella in pathogenesis and biofilm formation, the HVRs
of 26,587 flagellin sequences from the NCBI non-redundant database were analyzed for
hidden functional diversity through discovery of novel domain architectures. Detection
of new domain architectures is an effective bioinformatic strategy for novel function dis-
covery [62]. 62 such conserved domain architectures were discovered through CDART
(Figure 1.4). Even though no natural flagella has been known to have enzymatic activity,
uncharacterized protein domains with predicted enzymatic activity were found within
flagellin HVRs (Table 5.1).
The most frequent domain found was the M9 peptidase domain which is similar to Gluz-
incin family of zinc-dependent MPs, a flagellin architecture first identified by Doxey et
al. [63]. This domain was the 6th most common flagellin architecture detected (Figure
1.4), and was found in the highest number of species. This was further verified by in-
depth sequence analysis and structural modelling (Figure 1.5). PSI-BLAST searches re-
vealed the presence of this domain in 74 different bacterial species spanning 32 genera
Table 5.2 and were largely distributed amongst Proteobacteria and Firmicutes. Some of
these include animal pathogens such as Clostridium haemolyticum and Clostridium bo-
tulinum C/D str. DC5 as well as avid biofilm former Pseudoaltermonas tunicata. The
phylogenetic diversity of the species containing the peptidase domain indicates the mech-
anism to be lateral gene transfer (Figure 5.1).
In-depth sequence analysis (Figure 1.4), structural modelling (Figure 1.5) and reciprocal
PSI-BLAST searches verified that the peptidase domain is closely related to clostridial
collagenases, members of the gluzincin family. These identified flagellins contain a con-
served HExxH catalytic motif, which as indicated in Section 1.4.2, is characteristic of
gluzincin-like MPs.
1.6.1 Computational methods
The following work was a collaborative effort with Mike Mansfield at the University of
Waterloo.
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The CDART tool [64] was used to identify all proteins in the NCBI non- redundant pro-
tein database containing a predicted flagellin N-hypervariable region-C domain architec-
ture (search performed on January 31, 2017). Identified sequences possessing a central
gluzincin domain within the flagellin hypervariable region were retrieved and aligned us-
ing MUSCLE version v3.8.31[65] with default parameters, and visualized with Jalview
version 2.80b1 [66]. A structural model of the FliA(H)-hypervariable region was gener-
ated using the modeling servers SWISS-MODEL [67] and iTASSER [68] with the crystal
structures of clostridial collagenase G (PDB entry 2Y3U), H (PDB entry 4AR1), and
T (PDB entry 4AR8) as templates [50, 51]. Phyre 2.0’s intensive modeling procedure
was also used and yielded highly similar results [69]. Energy minimization and secondary
structure assignment were performed within the UCSF Chimera package [70].
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Figure 1.4: Structural model of the flagellar filament and identification of un-
characterized domains in the surface-exposed flagellin HVR.
(A) Structural model of the flagellar filament and constituent flagellins (left),
highlighting the interior flagellin N-terminal and C-terminal domain and the
surface-exposed hypervariable region domain (right). The model is based on the
structure of FliC from Salmonella (PDB 1UCU). Flagellin hypervariable regions
from the NCBI GenBank database were analyzed, revealing 61 putative domain
families including several with potential enzymatic function. (B) A schematic
depicting the commonly studied D2/D3 flagellin domain variant, as well as a novel
putative metallopeptidase domain predicted within 74 species. The lines below the
domains indicate regions matched by the Conserved Domain Database, which were
manually refined through subsequent analysis (Eckhard et al. 2017, in review).
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Figure 1.5: Sequence analysis and structural modeling of the proteolytic flag-
ellin family.
(A) 86-sequence multiple alignment of proteolytic flagellins, with key functional
motifs depicted assequence logos (B) including a putative Ca-binding site (i), the
zinc-binding HEXXH motif (includes the zinc-binding His233 and His237 and
general base Glu234 for hydrolysis; sequencenumbering according to FliA(H),
UniProt entry Q8RR94) (ii) and a motif containing the third zinc-binding residue,
Glu262 (iii). In addition, the hydrophobic basement-forming residue(Ala265)
located below the active site zinc is also conserved. (C) Structural model of
proteolytic flagella (FliA(H)-hypervariable region) from Clostridium haemolyticum
based on the peptidase domain of collagenase H from Clostridium histolyticum
(PDB 4AR1). (D) The zinc-binding HEXXH motif and Ca-binding site with
important residues labeled.(Eckhard et al. 2017, in review).
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1.7 Research objective
Computational prediction of a metallopeptidase domain in the HVR of various bacte-
rial species prompted the investigation and experimental validation of the first family of
HVR-associated proteases with predicted enzymatic activity. The investigation was car-
ried out using FliA(H) from Clostridium haemolyticum. This species was chosen due to
it’s industrial importance as an animal pathogen. The experimental approach was two-
fold and investigated FliA(H) from Clostridium haemolyticum both in vitro and in vivo.
Both approaches are covered in detail in Chapters 2 and 3.
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Chapter 2
General Materials and Methods
2.1 Bacterial plasmids
pET32a(+)
pET32a(+) is part of the pET expression vector collection designed to optimize expres-
sion and purification of recombinant proteins in bacterial cells. The plasmid pET32a+ is
derived from pBR322 and therefore maintains that naming convention. This pET vector
allows for constitutive and high-level expression of cloned sequences via a T7 promoter.
With multiple cloning sites available, the cloned sequences can have cleavable Trx TagTM
, His Tag R© or S TagTM for subsequent purification and detection of the expressed pro-
teins [71]. Other features include an ampicillin resistance gene for maintenance of the
plasmid in transformed bacterial cells as well as the pMB1 ori which results in a high
copy number of cells.
pET21a(+)
pET21a(+) is also a part of the pET expression vector collection designed to optimize
expression and purification of recombinant proteins in bacterial cells. Details about the
plasmid are the same as the vector described above with the only difference being that
this plasmid allows for a C-terminal His Tag R©.
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2.2 Bacterial strains
Escherichia coli - DH5α
Genotype: F− endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG purB20 φ80dlacZ δM15
δ(lacZYA-argF)U169, hsdR17(r−K m
−
K), λ
− [72].
This strain of E.coli is a common laboratory strain used in molecular biology. It is de-
rived from the K-12 strain and also referred to as a Hoffman-Berling 1100 strain deriva-
tive. This strain was used to maintain frozen stocks for some constructs.
Escherichia coli - BL21(DE3)
Genotype: F− ompT gal dcm lon hsdSB(r−B m
−
B) λ(DE3 [lacI lacUV5-T7p07 ind1 sam7
nin5 ]) [malB+]K−12 λS
This strain of E.coli is compatible with the pET expression vectors used for the expres-
sion of recombinant proteins. This strain is derived from the E.coli B strain. DE3 refers
to the λ prophage inserted in the strain which carries the T7 RNA polymerase gene and
lacIq. Since the gene for T7 RNA polymerase in under the control of a lac promoter, the
expression of the cloned sequence under the control of it’s respective T7 promoter (as is
the case with pET expression vectors) can be repressed until IPTG is used [73].
Clostridium haemolyticum
Strain ATCC R© 9650TM ; NCIMB 10664
This strain of Clostridium haemolyticum contains the flagellin variant FliA(H) and was
used for this project.
2.3 Maintenance of bacterial cultures
Escherichia coli strains were grown at 37◦C in LB broth and LB agar under aerobic con-
ditions with continuous shaking.
Clostridium haemolyticum was grown at 37◦C under anaerobic conditions. The anaerobic
gas mixture is defined as 80% N2, 10% CO2 and 10% H2.
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2.4 Standard molecular biology protocols for DNA
manipulation
2.4.1 Preparation of competent cells
Escherichia coli cells were grown overnight and subcultured 1:100 into fresh LB me-
dia. The cells were allowed to grow until the OD600 was between 0.4 to 0.6 (log phase).
Please refer to section 2.3 for details on cell culturing protocols. The cells were subse-
quently pelleted via centrifugation at 13,000 rpm and resuspended gently in ice-cold
0.1M CaCl2. The cells were centrifuged again at 6000 rpm at 4
◦C and resuspended in
ice-cold 0.1M CaCl2. The volume of 0.1M CaCl2 used for the final resuspension was
40% of the original volume of LB that the cells were grown in. Competent cells were
made freshly before every transformation.
2.4.2 Bacterial transformation
100 ng or 1µL of purified plasmid, mini-prepped plasmid (2.4.3) or ligated sample was
added to 100 µL of chemically-competent cells. This mixture was allowed to sit for 30
minutes on ice. After this, heat-shock of the cells was carried out by incubating the mix-
ture at 42◦C for 30 seconds. The cells were incubated on ice again, for 2 minutes. 1 mL
of fresh media was added to the mixture and allowed to incubate at 37◦C with shaking.
The cells were pelleted again at 13,000 rpm for 2 minutes and resuspended in 50µL of
fresh media and subsequently plated on LB agar plates containing the appropriate an-
tibiotic.
2.4.3 Plasmid DNA mini prep
Transformed bacterial cells were grown overnight and pelleted via centrifugation at 13,000
rpm for 2 minutes. The pellet was resuspended in 250 µL of resuspension solution. 250
µL of lysis buffer and subsequently 350 µL of neutralization buffer is added. The mix-
ture was then centrifuged for 5 minutes at 13,000 rpm. The supernatant was added to
a flow-through tube and centrifuged at 13,000 rpm for 2 minutes after which the flow-
through is discarded. The pelleted plasmid DNA is washed three times with ethanol con-
taining wash buffer and is then eluted in 30 µL of elution buffer.
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2.4.4 Restriction enzyme digestion
The steps in the protocol for restriction enzyme digestion depends on several factors.
Considering that a double-digest of 1000 ng of purified plasmid is being carried out, 1
µL of each restriction enzyme is added to the appropriate volume of purified plasmid
DNA corresponding to an amount of 1000 ng. 10X restriction digest buffer (based on
the kit and type of enzymes are being used) is then added to the reaction mixture. The
mixture is topped up to 20 µL with milliQ water. The reaction mixture is incubated at
the appropriate temperature and for the appropriate amount of time, depending on the
enzyme being used.
2.4.5 Agarose gel electrophoresis
To cast a 1% agarose gel, 50g of agarose is added to 50 mL of TAE buffer and heated
until all the agarose is dissolved. After the mixture is allowed to cool down for approx-
imately 2 minutes, 1:10,000 of GelRedTM nucleic acid stain is added. The mixture is
poured into the appropriate casting system, an appropriate comb is inserted and allowed
to dry. Excess TAE buffer is adding to the system containing the solidified gel and DNA
solution containing loading dye is added to the wells. The gel was run at 90V until the
loading dye ran off.
2.5 Standard protocols for Protein Analysis
2.5.1 SDS-PAGE
Protein samples were prepared with loading dye containing SDS and beta-mercaptoethanol.
These were loaded on a 4 % stacking / 12% resolving polyacrylamide gel and run at
100V for 1 hour [74]. The gel was stained using Coomassie blue.
2.5.2 BCA Protein Assay
PierceTM BCA Protein Assay kit (Thermo ScientificTM) was used for protein quantifica-
tion. It uses a standard curve generated from a range of diluted BSA protein standards
of known concentration. This was done by diluting a 2 mg/mL BSA standard to prepare
diluted standards at the following concentrations: 2.0, 1.5, 1.0, 0.75, 0.50, 0.25, 0.125,
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0.025 and 0 mg/mL. 25 µL of the standards along with the protein sample of unknown
concentration were plated in duplicate on a 96 well plate. A BCA working solution was
prepared by adding BCA reagent A and BCA reagent B at a ratio of 50:1. 200 µL was
added to each well containing the standard or the protein sample. The plate was in-
cubated at 37◦C for 30 minutes after which the absorbance was measured using a plate
reader at an absorbance of 562 nm. A standard curve of absorbance vs BSA concentra-
tion was generated and used to calculate the concentration of the protein sample.
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Chapter 3
Investigating protease activity from
FliA(H) in vitro
3.1 Background, Hypotheses and Rationale
As mentioned in Section 1.6, the 6th most common flagellin architecture, which was also
found in the highest number of species, contained a conserved HExxH motif within the
HVR of bacterial flagellins. Considering the multi-faceted role of flagella in pathogenesis
explained in section 1.2.2, Clostridium haemolyticum FliA(H) was chosen as the repre-
sentative flagellin variant for investigating the biological origins and function of this pro-
tein. Clostridium haemolyticum is an animal pathogen and is therefore of importance in
industry. Considering that the peptidase domain was predicted to be the most closely
related to clostridial collagenases, Clostridium haemolyticum was an ideal candidate for
studying the flagellin variant. To begin characterization of the putative enzymatic flag-
ellin variant, the first avenue of research was to study the HVR in vitro. The rationale
for this chapter is divided into two main questions that were asked and investigated. The
questions are as follows:
I. Does the HVR containing the gluzincin-like domain from Clostridium
haemolyticum FliA(H) produce a folded protein product?
To investigate whether the obtained protease domain was in fact functional, the HVR
of FliA(H) was cloned into an expression vector and transformed in to a compatible Es-
cherichia coli expression strain. The HVR without the N and C termini was used for
investigating recombinant expression.
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II. Does the folded protein exhibit catalytic activity similar to the predicted
function?
To investigate potential protease activity in FliA(H), two methods were employed.
1. Proteomic identification of substrate cleavage sites or PICS assay
PICS assay was developed in the Overall laboratory at the University of British
Columbia. This assay involves incubation of the test protease with a peptide li-
brary. The peptide library is obtained by digesting the genome of Escherichia coli
K-12 with the serine proteases, Trypsin and endoproteinase GluC to create two
’random’ peptide libraries. Trypsin cleaves peptide chains selectively at the C-
terminus of amino acids, lysine and arginine, except when followed by proline. En-
doproteinase GluC, on the other hand, cleaves peptides at the C-terminus of the
amino acid, glutamic acid. The two libraries are incubated separately with the test
protease. Cleavage of peptides by the test protease results in an exposed N ter-
minus. These prime-side cleavage products are labelled with biotin and purified
by affinity chromatography with streptavidin and sequenced using LC-MS/MS.
The corresponding sequences of the non-prime side are generated through bioin-
formatics. The sequences of all the cleaved peptides are aligned to get a consensus
sequence which corresponds to the putative substrate cleavage sites.
PICS was performed with the recombinant Trx-FliA(H)-HVR to investigate the
putative protease activity and whether its substrate cleavage profile is similar to
that of substrates cleaved by clostridial collagenases.
2. Quenched fluorometric (QF) assays
To further validate the substrate specificity of the recombinant FliA(H), QF pep-
tide cleavage assays with three synthetic quenched fluorometric peptides were car-
ried out. The synthetic peptides were chosen to validate the preference for the hy-
drophobic amino acid leucine in the P1’ position. The three peptides were as fol-
lows: ALG-L, which closely matches the cleavage specificity determined by PICS;
the classical MMP substrate QF24 (PLG-L); and PLG-V to test the dependency
for leucine in P1’.
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3.2 Methodology
3.2.1 Bacterial strains and construct design
All constructs were synthesized by Biobasic.Inc and are as follows:
1. Trx-FliA(H)-HVR
The hypervariable region of FliA(H) (Lys149-Ile448) WP 039229452.1) from Clostrid-
ium haemolyticum was cloned into the expression vector pET-32a(+) using the re-
striction enzymes KpnI and XhoI. N- and C- termini from FliA(H) were removed.
These cloning sites allow the fusion protein to have a cleavable His.Tag R©as well as
a Trx.TagTM. The Trx tag results in a 109 amino acid long thioredoxin protein to
be produced as a fusion with the cloned recombinant protein. It was used to ensure
the production of soluble recombinant proteins [75, 76]. The polyhistidine affinity
tag consists of several consecutive histidine residues and are appended to proteins
to allow for purification by nickel affinity chromatography with an Ni-NTA resin
[77].
2. SUMO-FliA(H)-HVR
The hypervariable region (300 amino acids long) of FliA(H) from C.haemolyticum
along with a N-terminal SUMO tag was cloned into the expression vector pET-
21a(+) using the restriction enzymes NdeI and HindIII. These cloning sites allow
the fusion protein to have an additional N-terminus His.Tag R©.
3. SUMO-FliA(H)-HVR, mutant
The SUMO-FliA(H)-HVR construct was modified by mutating the glutamic acid to
alanine (E234A) in the catalytic site -HExxH- within the hypervariable region (300
amino acids long) of FliA(H) by site-directed mutagenesis. This mutation would
knock-out HVR-associated protease activity and thus also remove possibility of
self-proteolysis. This results in a more stable protein that can be used for the pro-
duction of polyclonal antibodies as well as for X-ray crystallography studies.
All constructs were verified by protocols outlined in 2.4.
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3.2.2 Expression and purification of recombinant proteins
1. Expression and Purification of recombinant SUMO-FliA(H)-HVR pro-
tein
For expression of SUMO-FliA(H)-HVR recombinant proteins, the constructs were
transformed into BL21(DE3) cells as highlighted in Section 2.4.2. The transformed
cells were grown at 37 ◦C until OD600 was 0.4 at which point they were induced
with 0.1mM IPTG. The induced cells were allowed to grow at 30 ◦C for 3 hours
before they were harvested by centrifugation. Constructs were verified by protocols
described in Section 2.4.
SUMO-FliA(H)-HVR proteins were purified using Immobilized metal ion affinity-
flow chromatography. A nickel resin that chemically binds to His-tagged proteins
was added to a gravity-flow column. Cells were incubated with lysis buffer sup-
plemented with Protease Inhibitor Cocktail Set VII (Calbiochem R©#539138 M),
PMSF protease inhibitor and EDTA. The homogenate was then subjected to ly-
sis using a french press. The cell lysate was centrifuged to remove pelleted cell de-
bris. The supernatant was incubated with 60% ammonium sulphate overnight. The
overnight suspension was subsequently centrifuged to obtain the pelleted recom-
binant protein. The pellet was resuspended in excess lysis buffer and incubated
with the charged Ni-NTA agarose resin (Qiagen-Cat No. 30210) for 45 minutes.
The lysate was collected as flow-through and discarded. The bound protein was
eluted with a high imidazole elution buffer. Flow through was collected in multi-
ple fractions until OD280 < 0.1 and subsequently concentrated to 10 mL using a
nitrogen-based concentrator. The concentrated protein was subsequently incubated
overnight (10 hrs) with SUMO protease. The SUMO protease digested sample was
buffer exchanged into 25mM HEPES buffer, pH 7.5 and subsequently incubated
with the Nickel resin again. The elutant was frozen in 10µL pellets in liquid nitro-
gen and stored at -80◦C.
Recipes for buffers used is provided in the Appendix.
2. Expression and Purification of recombinant Trx-FliA(H)-HVR protein
Expression and purification of recombinant Trx-FliA(H)-HVR protein was done by
Biobasic.Inc
The Trx-FliA(H) construct was transformed into competent BL21(DE3) cells. Cells
were grown in LB media supplemented with ampicillin at 37◦C until the logarith-
mic phase was reached after which it was induced with 0.1 mM IPTG for 3 hours
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at 30◦C. The His R©tagged proteins were purified using Nickel affinity chromatogra-
phy and further purified by size-exclusion via gel-filtration. Purification was con-
firmed by SDS-PAGE as outlined in section 2.5.1.
3.2.3 PICS Assay
Proteomic identification of substrate cleavage sites or PICS assay was developed and per-
formed by the Overall laboratory at the University of British Columbia [78]. The proto-
col was written and carried out by Dr. Ulrich Eckhard.
Proteomic identification of FliA(H) cleavage sites by PICS using whole proteome pep-
tide libraries were performed [79, 80, 81, 78]. In brief, as a proteome source to generate
peptide libraries, cell pellets collected from Escherichia coli K-12 cultures were lysed in
presence of protease inhibitors and cell debris was removed by centrifugation. Soluble
proteins were denatured with 4 M guanidine hydrochloride and cysteine side chains were
reduced and protected with iodoacetamide. After chloroform/methanol precipitation,
pellets were re-suspended and digested with trypsin (TPCK treated, Sigma-Aldrich) or
GluC (Staphylococcus aureus protease V8, Worthington) at a protease to proteome ra-
tio of 1:100 (w/w). Primary amines were then blocked by reductive dimethylation and
samples were desalted by size exclusion chromatography and further purified by reversed-
phase chromatography. Eluates were concentrated, re-suspended in water, and stored
at -80◦C as peptide libraries of 200 µg. PICS cleavage assays were performed by incu-
bating one peptide library aliquot with active recombinant FliA(H). Cleaved peptides
presenting neo N-termini were selectively biotinylated, affinity purified using strepta-
vidin Sepharose and desalted using reversed-phase solid phase extraction. Eluates were
vacuum dried to near dryness and stored at -80◦C until LC-MS/MS analysis on a high
resolution quadrupole Time-Of-Flight mass spectrometer (impact II, Bruker Daltonics).
Mass spectrometry
The protocol was written and carried out by Dr. Ulrich Eckhard.
LC-MS/MS analysis was performed on a nano-LC system (EASYnLC1000, Thermo Sci-
entific, USA) coupled to a high resolution quadrupole Time-Of-Flight mass spectrometer
(Impact II, Bruker Daltonics) using the CaptiveSpray ionizationsource (Bruker Dalton-
ics), a 2-cm long, 75-µm inner diameter fused silica trap column, and a 20 cm long, 50-
µm inner diameter fused silica fritted analytical column. The trap column was packed
with 5-?m diameter Aqua C18 beads (Phenomenex, USA), while the analytical column
34
was packed with 1.9-µm diameter Reprosil-Pur C18-AQ beads (Dr.Maisch, Ammer-
buch, Germany). Peptides were eluted using a 0 to 80% gradient of organic phase over
90 min. Buffer A was 0.1% formic acid and buffer B was 100% (v/v) acetonitrile with
0.1% formic acid. MS/MS data were acquired automatically using the otofControl soft-
ware (Bruker Daltonics) for information-dependent acquisition. Error of mass measure-
ment was usually within 5 ppm and was not allowed to exceed 10 ppm. Peak lists and
mzXML-files of the acquired high resolution Time-Of-Flight mass spectrometer data
were created using the Compass DataAnalysis software 4.2 (Bruker Daltonics).
LC-MS/MS of recombinant FliA(H)-HVR
The protocol was written and carried out by Dr. Ulrich Eckhard.
Tandem mass spectrometry was performed essentially as described in detail by [82]. In
brief, free sulfhydryl groups of 10 µg of FliA(H) hypervariable region protease in 1x phos-
phate buffer saline (PBS; 10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7mM
KCl, pH 7.4) were alkylated with iodoacetamide (20 mM iodoacetamide, 1 h, 20◦C) after
initial cysteine reduction with 10 mM dithiothreitol (DTT; 30 min, 20◦C). Labeling was
stopped by adding further DTT (10 mM, 15 min, 20◦C). Trypsin Gold (Promega)was
added in a 1:50 w/w ratio and the sample was digested over night at 37 C. The reac-
tion was stopped by adding formic acid to a final concentration of 2.5% and desalted
by C18-STAGE tip [83] prior mass spectrometry analysis. LC-MS/MS analysis was per-
formed as described below. Peptides were identified at a 1% false discovery rate from a
combined UniProt database, containing both human and Escherichia coli proteins and
supplemented by our target protein, thioredoxin-tagged FliA(H)-hypervariable region.
Two search engines, Mascot v2.4.1 (Matrix Science, London, UK) and X!Tandem [84]
were used in conjunction with Peptide Prophet [85] as implemented in the Trans Pro-
teomic Pipeline v.4.6. Search parameters included a mass tolerance of 15 ppm for the
parental ions and 0.1 Da for fragment ions, and allowed for one missed cleavage. Car-
bamidomethylation of cysteine residues (+57.02 Da) was used as fixed modification,
whereas methionine oxidation (+15.99 Da) was set as variable. Peptide lists from both
search engines were combined within the Trans Proteomic Pipeline for further analysis.
In-gel digestion and mass spectrometry
The protocol was written and carried out by Dr. Ulrich Eckhard.
In-gel digests were performed as described by [86]. Recombinant FliA(H) was resolved by
12% SDS-PAGE, stained with Coomassie G-250, and nine bands were excised, destained
35
with 60% acetonitrile, 20mM ammonium bicarbonate, and then washed in 100% acetoni-
trile before lyophilization. Gel bands were rehydrated with 10 µL Trypsin Gold (Promega)
in 20 mM ammonium bicarbonate (12 ng/µL) by passive diffusion for 1 h at 4 ◦C. Ex-
cess solution was removed and 20 µL 20 mM ammonium bicarbonate was added to the
gel plugs and digested overnight at 37 ◦C. Supernatants were removed and three rounds
of active extraction were performed using 20 µL of 1% formic acid, and two times 20 µL
of 30% acetonitrile, 1% formic acid. All supernatants were pooled and concentrated to
10 µL using a SpeedVac, and 1-2 µL were analyzed by LC-MS/MS using the same set-
up as described in section 3.2.3, but 30 min gradients. Search parameters included 15
ppm tolerance for MS and 0.10 Da for MS/MS, variable methionine oxidation and propi-
onamide cysteine, and a maximum of one missed cleavage.
Spectrum to peptide matching and identification
The protocol was written and carried out by Dr. Ulrich Eckhard.
Peptides were identified at a 1% false discovery rate from the UniProt Escherichia coli
K12 database (November 2013) using two search engines, Mascot v2.4.1 (Matrix Science,
London, UK) and X! Tandem [84], in conjunction with Peptide Prophet [85] as imple-
mented in the Trans Proteomic Pipeline v.4.6. Search parameters included a mass tol-
erance of 15 ppm for the parental ions and 0.1 Da for fragment ions, and allowed up to
two missed cleavages. The following fixed peptide modifications were used: carbamidomethy-
lation of cysteine residues (+57.02 Da) and dimethylation of lysine -amines (+28.03
Da). N-terminal dimethylation of library carryover peptides (+28.03 Da), methionine ox-
idation (+15.99 Da), and thioacylation of protease-generated neo N-termini (+88.00 Da)
were set as variable modifications. Peptide lists from both search engines were combined
within the Trans Proteomic Pipeline for further analysis. A web-based bioinformatics
tool [87] was used to reconstruct the non-prime side of each identified unique cleavage
site [52, 81]. Obtained cleavage sites were aligned along the scissile peptide bond and vi-
sualized as heat maps in GnuPlot (www.gnuplot.info) and iceLogos [88].
3.2.4 Quenched fluorometric assays
Quenched fluorometric assays were performed by Iain Wallace (University of Waterloo)
and Dr.Ulrich Eckhard (University of British Columbia).
Stock solutions (1.0 mM) of synthetic quenched fluorescence (QF) peptide substrates
(GenScript Inc.) were dissolved in DMSO and working stocks (100 µM) were prepared
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using the molar extinction coefficient of the conjugated quencher, (2,4)-dinitrophenyl, of
6.985 cm−1mM−1 at 400 nm. Purified recombinant FliA(H)-HVR region protease was
incubated at a final concentration of 0.5 µM with 10 µM QF-peptide substrate in 100
µL of 50 mM Hepes, 150 mM NaCl, 10 mM CaCl2, pH 7.5, in presence of HALT pro-
tease inhibitor cocktail (Life Technologies) plus/minus 20 mM EDTA at 37◦C. The in-
hibitor cocktail was present to inhibit activity for contaminating proteases. Three differ-
ent quenched fluorescent peptides (PLG - L, Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg; ALG
- L, Mca-Ala-Leu-Gly-Leu-Dpa-Ala-Arg; and PLG-V, Mca-Pro-Leu-Gly-Val-Dpa-Ala-
Arg) were tested using a multi-wavelength fluorescence scanner (POLARstar OPTIMA,
BMG Labtechnologies). The excitation and emission wavelengths were 320 and 405 nm,
respectively. Fluorescence was measured in arbitrary units over 30 minutes at 45 seconds
intervals. Values are means of triplicate measurements.
3.3 Results
3.3.1 Recombinant FliA(H)
As mentioned earlier in the chapter, the recombinant FliA(H) from C. haemolyticum was
designed to only express the HVR containing the candidate metallopeptidase domain.
Details regarding the construct are shown in figure 3.1. The recombinant protein was
expressed and purified to high purity. This was confirmed by LC-MS/MS (Figure 3.2). It
also confirmed the absence of contaminating proteases.
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Figure 3.1: Design and expression of Trx-FliA(H)-HVR
(A) The recombinant flagellin-associated protease was designed by trimming the N
and C termini from FliA(H) from Clostridium haemolyticum. (B) The HVR was
cloned into the expression vector pET32a(+) to allow for translational fusions with
thioredoxin and His tags. (C) Expression of a soluble purified product was verified
using SDS-PAGE.
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MSDKIIHLTD DSFDTDVLKA DGAILVDFWA EWCGPCKMIA PILDEIADEY 
QGKLTVAKLN IDQNPGTAPK YGIRGIPTLL LFKNGEVAAT KVGALSKGQL 
KEFLDANLAG SGSGHMHHHH HHSSGLVPRG SGMKETAAAK FERQHMDSPD 
LGTDDDDKMK GLKTGWIEKS VENIKTAYGI EPTGANKLKV TISDDGAYGV 
LASVTPKTGE FELHIDSSDF EKGDGESGNN IHGKLYDDRI IQHEMTHAVM 
NDALGIDKMN DLHDKNKLWF IEGTAEAMAG ADERVKDIIG NDTQTGIDNT 
KLSKLATRAD ALLNGVSWNS SDEDYAAGYL MVKYIASKGI DLKAVMKEIK 
NTGASGLDNK IDLTNLKIDF KNNLENYIKD ISKVHLDWDD DEKDVGSILG 
SDHGHGDIKA EDVVKGTTPE KEQPLDKFKI IWPDDNSDNT TGKIQLQVGA 
NEGQSITILE
Blue: trx-domain; Green: hexahistidine-tag; Red: enterokinase cleavage site;
Black: peptidase domain of C. haemlyticum FliA(H). Peptides in bold were 
identified by MS/MS analysis at a false discover rate (FDR) of 1%.
1
51
101
151
201
251
301
351
401
451
LC-MS/MS analysis of Trx::FliA(H)-HVR by trypsin
92% sequence coverage
a
b Identified proteins at a protein false discovery rate of 1%
Proteins identified with >10 peptide spectrum matches are shown.
UniProt Gene protein description tot indepspectra
percent share
of spectrum ids
Q8RR94 
(mod) Trx::FliA(H)-HVR Trx::FliA(H)-HVR 11630 95.1
P17169 GLMS_ECOLI Glutamine-fructose-6-phosphate transaminase 242 2.0
P0A6Y8 DNAK_ECOLI Chaperone protein DnaK 131 1.1
P0A9K9 SLYD_ECOLI FKBP-type peptidyl-prolyl cis-trans isomerase 105 0.9
P0A6T5 GCH1_ECOLI GTP cyclohydrolase 1 32 0.3
P77398 ARNA_ECOLI Bifunctional polymyxin resistance protein ArnA 21 0.2
P0ACJ8 CRP_ECOLI cAMP-activated global transcriptional regulator CRP 22 0.2
P0A7M2 RL28_ECOLI 50S ribosomal protein L28 17 0.1
P76270 MSRC_ECOLI Free methionine-R-sulfoxide reductase 12 0.1
P64588 YQJI_ECOLI Transcriptional regulator YqjI 11 0.1
P0AFD1 NUOE_ECOLI NADH-quinoneoxidoreductase subunit E 12 0.1
Figure 3.2: LC-MS/MS
(a) LC-MS/MS results for the recombinant FliA(H)-HVR protein, indicating 92%
sequence coverage, and (b) illustrating together with our in-gel digests the high
sample purity.
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3.3.2 PICS peptidase specificity assays
Protease activity of the gluzincin metalloprotease domain containing recombinant pro-
tein Trx-FliA(H)-HVR was confirmed using the PICS peptide cleavage assay. The re-
combinant protein cleaved 391 peptides in the trypsin-generated Escherichia coli K-12
library and 498 peptides in the GluC generated library. Two different proteome libraries
were used to exclude bias. The peptides cleaved in both libraries were analyzed to as-
sess the amino acid preference for prime and non-prime subsites flanking the hydrolyzed
scissile peptide bond i.e., P1-P1’. The cleaved sequences were aligned at the scissile pep-
tide bond and used to generate a logo (Icelogo) representing the amino acid abundance
at each position. This data is also represented as heat maps (Figure 3.3). The recom-
binant protein was shown to be a protease with substrate specificity similar to that of
mammalian MMPs i.e. a preference for a leucine residue in the P1’ position and other
hydrophobic amino acids in the P2’ and P3’ positions. Though this differs from the pre-
dicted homology with clostridial collagenases, it does agree with the structural model
that does not contain the ’double-glycine’ motif upstream of the HExxH motif. This mo-
tif is a key determinant of substrate specificity at the P1’ position for clostridial colla-
genases [50, 48]. Furthermore, it is also in concert with deep pocket S1’ subsite usually
found in MMPs (Figure 3.5).
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Figure 3.3: PICS assay with recombinant Trx-FliA(H)-HVR.
(A) PICS assay carried out with a trypsin digested Escherichia coli K-12
proteome library. (B) PICS assay carried out with a GluC digested Escherichia
coli K-12 proteome library. The analysis of cleaved biological peptides have been
shown at prime and non-prime positions flanking the scissile peptide bond. The
total occurrence and fold enrichment for each amino acid at each position have
been represented as heat maps. The logo generated shows the preference for
leucine at P1’ position and other hydrophobic amino acids at P2’ and P3’ positions
in each library.
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3.3.3 Quenched fluorometric peptide cleavage assays
The QF peptide cleavage assay was carried out to confirm substrate specificity. It was
carried out with three different fluorophore conjugated peptides which are as follows: (i)
ALG-L, to test dependency of Leucine in the P1’ position as determined by the PICS
assay; (ii) PLG-L, a classical MMP substrate and (iii) PLG-V. Fluorescence emission
progress curves shown in Figure 3.4 shows that there was an increase in fluorescence
with time for the two peptides that had Leucine in the P1’ position (ALG-L, PLG-L).
Increase in fluorescence means that the recombinant protease was able to cleave the two.
When leucine was replaced with valine in the P1’ position (PLG-V), there was no change
in fluorescence thus showing that it was unable to cleave the peptide. Furthermore, pep-
tide cleavage activity was also knocked out in the presence of EDTA when ALG-L was
incubated with Trx-FliA(H)-HVR thus showing that the proteolytic activity is depen-
dent on divalent cations. It is important to note that assays with inhibitors of all other
protease classes did not have an effect on activity. Additionally, as shown in the struc-
tural model represented in Figure 1.5, Asp206 (subsitutes Glu430 in clostridial collage-
nase H) along with the backbone oxygens of Asn241, Leu244, and Asp247 residues, forms
a calcium-binding site in close proximity to the active site.
To further strengthen this claim, QF assay was performed with purified mutant FliA(H)
in which the catalytic residue Glu234 was changed to alanine. There was a loss of ac-
tivity when mutant FliA(H) was incubated with the QF-peptide ALG-L. This confirms
MMP-like activity from recombinant FliA(H).
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Figure 3.4: Quenched Fluorometric peptide cleavage assay with Trx-FliA(H)-
HVR.
QF assays were carried out with 3 different synthetic peptides to verify the results
obtained via PICS. Increase in fluorescence over time is shown for peptides with
leucine in the P1’ position, however the fluorescence stays constant for the peptide
with valine in the P1’ position. Divalent cation dependent activity was shown
when activity was abolished for ALG.L in the presence of EDTA.
3.3.4 Peptide Docking Model
Performed by Dr. Ulrich Eckhard.
High resolution peptide docking (figure 3.5) was done using the homology model of the
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flagellin-associated protease (as shown in Figure 1.5) and a nonapeptide which mimics
the conserved specificity motif as predicted by PICS (AVTYY-LVIA). The peptide fits
perfectly within the predicted active site. The model also highlights the deep hydropho-
bic S2 and S1’ pockets in the active site.Supplementary	Fig.	5	 Eckhard	et	al.	2017	
	
	
Supplementary	 Fig.	 5.	 Peptide	 docking	 model	 using	 the	 predicted	 structure	 of	 the	 protease	 domain	 of	 Clostridium	
haemolyticum	 FliA(H)	 and	 the	 (AVTYY↓LVIA)	 nonapeptide	 based	 on	 the	 consensus	 specificity	 determined	 by	 PICS.	 (a)	
Whole	 view	 of	 FliA(H)	 protease	 domain-peptide	 docking	model.	 (b)	 A	 zoomed	 view	 of	 the	 peptide-binding	 groove	with	
peptide	 residues	 labeled	 in	white	 and	 the	 cleavage	 site	 indicated	by	a	 red	arrow.	 (c)	A	 second	 zoomed	view	 rotated	25	
degrees	counterclockwise	revealing	steric	complementarity	between	the	peptide	and	binding	groove.	
Figure 3.5: Peptide docking odel
Peptide docking model using the predicted structure of the protease domain of
Clostridium haemolyticum FliA(H) and the (AVTYY-LVIA) nonapeptide based on
the consensus specificity determined by PICS. (a) Whole view of FliA(H) protease
domain-peptide docking model. (b) A zoomed view of the peptide-binding groove
with peptide residues labeled in white and the cleavage site indicated by a red
arrow. (c) A second zoomed view rotated 25 degrees counterclockwise revealing
steric complementarity between the peptide and binding groove (Eckhard et al.
2017, in review)
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3.4 Discussion and future directions
The recombinant protein Trx-FliA(H)-HVR was shown to have protease activity by us-
ing PICS and quenched fluorometric assays. As outlined in section 3.2.3, the PICS assay
was carried out with two Escherichia coli K-12 derived peptide libraries, digested with
GluC and Trypsin respectively. The recombinant protein cleaved 391 peptides in the
trypsin-generated library and 498 in the GluC derived library. The peptides cleaved in
both libraries were analyzed to assess the amino acid preference on the prime and non-
prime sides of the hydrolyzed scissile peptide bond. The cleaved sequences were used to
generate a logo (Icelogo) representing the amino acid abundance at each position. The
recombinant protein was shown to be a protease with substrate specificity more simi-
lar to that of mammalian MMPs (a preference for a leucine residue in the P1’ position
and other hydrophobic amino acids in the P2’ and P3’ positions) than clostridial colla-
genases. Though this differs from the predicted homology with clostridial collagenases,
it does agree with the structural model that has a ’double-glycine’ motif upstream of the
HExxH motif. This motif is responsible for determining the substrate specificity at the
P1’ position [50, 48]. The substrate specificity was confirmed by quenched fluorometric
assays. As outlined in 3.2.4, the assays were carried out with 3 synthetic peptides. Trx-
FliA(H)-HVR with ALG-L and PLG-L showed an increase in fluorescence with time.
This was further validated with the no change in fluorescence when PLG-V was used as
well as ALG-L with the metal chelator EDTA. This shows that the presence of leucine
in the P1’ position is important for protease activity. Loss of activity in the presence of
EDTA emphasizes the importance of divalent cations for its activity.
Biochemical characterization of the recombinant protein was the first step towards un-
derstanding the biological function of the protein. An important future direction cur-
rently underway in the laboratory of Dr. Todd Holyoak at the University of Waterloo,
is obtaining the structure of FliA(H)-HVR protein via X-ray crystallography. Under-
standing the tertiary and quarternary configuration of this protein would give us more
insight into the substrates it may prefer and therefore, elucidate its broader biological
function. As outlined in 3.2.1, we have designed constructs for purification and crys-
tallization of FliA(H)-HVR. These constructs will allow the recombinant protein to be
expressed as a fusion with a cleavable SUMO tag. Having a SUMO tag assists high ex-
pression of recombinant protein by increasing protein solubility. A SUMO affinity tag is
also advantageous because it evades the need for a linker peptide since it forms a cova-
lent bond directly with the recombinant protein. The tag is also easily cleaved by SUMO
protease which doesn’t cleave the target protein [77]. Additional His.Tag R©allows for
its purification by Ni-NTA affinity chromatography. Additionally the catalytic motif
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(HExxH) within the cloned HVR of FliA(H) has been modified by replacing the zinc-
binding glutamic acid residue with alanine (E234A). This prevents the possibility of self-
proteolysis while maintaining the structural integrity of the protein.
.
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Chapter 4
Investigating protease activity in
vivo from Clostridium
haemolyticum
4.1 Hypotheses and Rationale
Following from Section 3.3, the recombinant FliA(H) protein was shown to have catalytic
activity. Though the prediction based on structural modelling and sequence homology
indicated that the recombinant Trx-FliA(H)-HVR protease is similar to clostridial colla-
genases, part of the gluzincin clan, experimental evidence based on PICS and QF assays
showed that the substrate specificity is more similar to that of human MMPs. Given
that this flagellin variant from an animal pathogen is catalytically active in vitro and
exhibits MMP-like activity, there are two follow-up questions.
I. Are proteolytic flagellins components of the polymerized flagella?
To understand the role of this catalytic variant within the polymerized flagella, we aimed
to determine its localization within flagellar filaments and the relative abundance. This
was achieved by purifying the flagellar filament proteins by ultracentrifugation directly
from C. haemolyticum. These proteins were then isolated using SDS-PAGE and sequenced
using LC-MS to semi-quantitatively assess the relative abundance of FliA(H).
To visualize the presence of the proteolytic variant within the polymerized flagella, im-
munogold TEM was carried out with purified flagellar filaments from C.haemolyticum
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Polyclonal primary antibodies against FliA(H)-HVR were produced in rabbit (Biobasic
Inc.) and used to label the proteolytic flagellin. ECL-based western blotting was used for
validation of the specificity of the primary antibody for both the recombinant FliA(H)-
HVR as well as full-length proteolytic flagellin from isolated flagellar proteins. Anti-
rabbit colloidal gold-conjugated secondary antibodies were then used to visualize these
variants using TEM.
II. Does the polymerized flagella exhibit predicted activity?
To assess whether the polymerized flagella from Clostridium haemolyticum exhibits cat-
alytic activity, PICS and quenched fluorometric assays with isolated flagellar filaments
were carried out.
Addressing these two questions would confirm the existence of an active flagella-associated
protease. Biochemical characterization with the assays mentioned above would highlight
the substrate specificity of the protease and thus bring us closer to understanding the
biological role of this protease in Clostridium haemolyticum.
4.2 Methodology
4.2.1 Isolation of flagellar proteins from C. haemolyticum
The flagellar filaments from Clostridium haemolyticum was isolated and purified by Dr.
John W. Austin at Health Canada.
Cultures of Clostridium haemolyticum were grown overnight, harvested and re-suspended
in 1/20th of it’s original volume (0.1 M Tris-HCl pH 7.0). Flagella was removed from
whole cells by mechanical shearing using a Teflon tissue homogenizer. The flagellar pro-
teins were then separated from the homogenate by two low-speed centrifugations (5,000
g; 15 min) followed by a round of ultracentrifugation at 130,000 g for 1 hr (70 Ti rotor,
Beckman Coulter, Mississauga, Ontario, Canada). The pellets were washed once in ul-
trapure water and followed by a final centrifugation at 130,000 g for 1 hr. The pellets
were resuspended in 50% glycerol and stored at -20◦C [89]. Purification was confirmed
by SDS-PAGE and quantified using by BCA protein assay as outlined in section 2.5.2.
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4.2.2 Peptide sequencing by LC-MS/MS
SDS-PAGE (2.5.1) using a 4 (stacking) -12% (separating) Bis-Tris Plus (InvitrogenTM)
was used to separate the purified flagellar proteins based on size. Protein bands seen at
approximately 62 kDa and 46 kDa on the gel were excised. These were further processed
by in-gel trypsin digestion and sequenced using mass spectrometry, LC-MS/MS (Ad-
vanced Analysis Centre, University of Guelph, Guelph, Ontario, Canada).
4.2.3 Immunogold Transmission Electron Microscopy
Gold-conjugated secondary antibodies were supplied by Dr. Simon Chuong at the
University of Waterloo.
Preparation of antibodies and protein samples
The concentration of antibodies and isolated flagellar proteins used for immunogold TEM
was optimized using enhanced chemiluminescent (ECL)-western blotting with purified
recombinant Trx-FliA(H)-HVR protein, isolated flagellar proteins and primary anti-
FliA(H) antibody produced in rabbit (Biobasic Inc.). The secondary antibody used was
an HRP-conjugated anti-rabbit IgG produced in goat. The detection of protein occurs
via a chemiluminescence reaction, in which horseradish peroxidase (HRP) catalyzes the
oxidation of luminol (ECL substrate). This reaction causes the substrate to decay and as
a result, emit light proportional to the amount of protein present.
Western Blot
Varying concentrations (0.5 ng, 1 ng, 10 ng, 100 ng, 250 ng) of purified recombinant pro-
tein were separated by SDS-PAGE using a 10/4% polyacrylamide gel. The gel was then
transferred onto a 0.2 µm PVDF Blotting membrane (AmershamTMHybondTM) using a
Trans-Blot R©SD Semi-Dry Electrophoretic Transfer cell (Bio-Rad). The transfer was run
at 20V for 25 minutes. Equal loading of protein was determined by ponceau staining.
The membrane was then blocked with 5% skim milk (Oxoid R©) in 1 × TBS-T for 1 hour
at room temperature. The membrane was incubated in primary Anti-FliA(H) antibody
(Biobasic Inc.) overnight at 4◦C with gentle shaking. The membrane was then washed
three times, each 10 minutes with 2% skim milk in 1 X TBS-T. The membrane was then
incubated with HRP-conjugated anti-rabbit IgG secondary antibody diluted 1:100,000
in 1 X TBS-T with 2% skim milk for 2 hours at room temperature with gentle shaking.
The membrane was washed and then incubated with ECL for 5 minutes. Excess ECL
was removed and the blot was analyzed using a gel-imager.
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Immunohistrochemistry and TEM
50 ng of isolated flagella from Clostridium haemolyticumwas plated on the formvar-coated
side of a nickel grid (Ted Pella, inc. Lot# 221014; 200 mesh, Ni; Prod No. 01800N). The
protein was allowed to dry for 15 minutes after which it was blotted dry using edges of
a WhatmanTMfilter paper. The grid was then incubated in 100 µL of blocking buffer
for 2 hours before incubating it with 100 µL of anti-FliA(H) primary antibody diluted
1:100 from stock concentration of 2mg/ml in wash buffer. The primary antibody incuba-
tion was carried out overnight in a wet chamber at 4◦C after which the grid was washed
three times with wash buffer. For immunogold labelling, grids were incubated in anti-
Rabbit IgG-Gold secondary antibody produced in goat, diluted 1:100 in wash buffer,
for 1 hour. The grid was then washed 3 times, once with wash buffer, 1 X PBS (Fisher
BioReagentsTM) and deionized water each.The grids were then negatively stained with
1% w/v ammonium molybdate. TEM was carried out using a Philips CM10 microscope
running at 60 kV at the University of Waterloo.
4.2.4 PICS Assay with purified flagellar filaments
Please refer to section 3.2.3 for methodology.
4.2.5 Quenched fluorometric assays
Please refer to section 3.2.4 for methodology.
4.3 Results
4.3.1 LC-MS/MS
Flagellar proteins were isolated from Clostridium haemolyticum, separated by SDS-PAGE
and analyzed by LC-MS/MS. As shown in figures 4.1 and 4.2, the proteolytic flagellin
FliA(H), forms the second dominant component of the polymerized flagella. The pro-
teolytic flagellin was identified with 79% coverage and contains the HExxH motif. The
most dominant component was identified as a non-proteolytic “structural flagellin” (NCBI
accession WP 039229459) with 82% sequence coverage.
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Figure 4.1: Isolation of flagellar filaments from Clostridium haemolyticum
Flagellar filaments were isolated from Clostridium haemolyticum and separated
using SDS-PAGE. The protein bands seen on the gel were further analyzed using
LC-MS/MS. The primary component was identified to be a non-proteolytic
“structural” flagellin (NCBI accession WP 039229459) and the second most
dominant component was identified to be FliA(H).
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Supplementary	Fig.	6	 Eckhard	et	al.	2017	
	
	
Supplementary	 Fig.	 6.	Sequence	 coverage	of	 the	Clostridium	haemolyticum	 fliA(H)	obtained	 through	mass	 spectrometry	
analysis	of	the	excised	band	(ii)	from	Fig.	3E.	
Figure 4.2: Sequence coverage of the Clostridium haemolyticum FliA(H) ob-
tained through mass spectrometry analysis
4.3.2 Immunogold TEM
To investigate the localization of proteolytic flagellins on assembled flagellar filaments,
immunogold TEM was performed on purified filaments. Polyclonal anti-FliA(H) primary
antibodies were raised and purified against the HVR of FliA(H). The specificity of these
antibodies was verified using ECL-based western blotting for both the recombinant Trx-
FliA(H)-HVR protein and the purified flagellar filaments (Figure 4.3). Anti-FliA(H) pri-
mary antibodies along with gold-conjugated anti-rabbit antibodies were used to label the
filaments. Immuno-labelled filaments were visualized using TEM imaging. This showed
that the proteolytic flagellins localize uniformly along the length of both filament bun-
dles and individual filaments (figure 4.4).
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Supplementary	Fig.	7.	Western	blot	validation	of	the	anti-FliA(H)-HVR	antibody	using	(a)	expressed	recombinant	FliA(H)-
HVR	and	(b)	purified	flagellar	filaments	from	Clostridium	haemolyticum.	The	molecular	weights	of	the	major	bands	match	
the	theoretically	computed	values	(indicated	on	the	right).	Figure 4.3: ECL-based western blot for verification of anti-FliA(H) primary
antibodies
Primary antibodies were raised against the HVR of FliA(H) in rabbit. (A)
Detection of recombinant FliA(H)-HVR at 50.1 kDa is shown. (B) Detection of
the flagellin variant at 61 kDa verifies the specificity of anti-FliA(H) primary
antibodies.
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Figure 4.4: Immunogold TEM with flagellar filaments
(A) TEM with isolated flagellar filaments from Clostridium haemolyticum
(B)(C)(D) Transmission electron micrograph shows gold-labelled FliA(H)
localizing along the flagellar filaments in Clostridium haemolyticum.
4.3.3 PICS and QF peptide cleavage assays with purified flagel-
lar filaments
To investigate whether native flagella from Clostridium haemolyticum exhibited prote-
olytic activity, PICS and QF peptide cleavage assays were carried out with purified flag-
ellar filaments. PICS assay revealed that these filaments do exhibit peptidase activity as
they cleaved 269 peptides in the trypsin digested Escherichia coli K-12 proteome library
with specificity similar to that of recombinant FliA(H) (Figure 4.5). QF assays also re-
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vealed that the filaments cleave the peptide ALG-L. As shown in Figure 4.6, the activity
was abolished in all controls. Furthermore, when the filaments were ultracentrifuged, the
supernatant only had residual activity (12.8%) thus confirming that the protease activity
was associated with flagella as opposed to other proteases.
Figure 4.5: PICS assay with isolated flagellar filaments
PICS assay was performed with isolated flagellar filaments from Clostridium
haemolyticum to profile the protease in vivo. Cleaved peptides from the trypsin
digested Escherichia coli K-12 proteome library were analyzed. The total
occurrence for each amino acid at both prime and non prime positions flanking the
scissile peptide bond are represented as heat maps. The Icelogo shows substrate
specificity similar to that of MMPs i.e. preference for hydrophobic amino acids at
the P1’ position.
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Figure 4.6: QF assay with isolated flagellar filaments
The plot shows an increase in fluorescence over time with Clostridium
haemolyticum flagella. The activity is abolished in the two negative controls in the
absence of flagella. The activity is also abolished in the presence of Halt Protease
Inhibitor cocktail.
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4.4 Discussion and future directions
Analysis of flagellar proteins from Clostridium haemolyticum shows that the catalytically
active flagellin variant is the second-most dominant component of the polymerized flag-
ella. Considering that Clostridium haemolyticum was grown in normal conditions i.e. not
in the presence of the hypothesized substrate, this variant seems to be expressed consti-
tutively. This is still speculative considering that further experimentation would be into
the regulation of this protein is required.
Immunogold TEM with isolated flagellar proteins gave us additional evidence for the
presence of the variant. The arrangement of 10 nm colloidal gold particles on the trans-
mission electron micrograph indicate that the flagellin-associated protease localizes along
the surface of the flagella. To obtain more precise evidence regarding how this protease
is arranged within the polymerized flagella, immunogold TEM with fixed whole Clostrid-
ium haemolyticum cells would be ideal. This is one of the future directions this project
will take. In summary, the both, peptide sequencing and immunogold TEM, give us pre-
liminary evidence about the presence of FliA(H) in Clostridium haemolyticum.
Evidence for catalytic activity from polymerized flagella in vivo was obtained by re-
peating the PICS and quenched fluorometric assays with isolated flagellar proteins. The
PICS assay was repeated with a peptide library derived from trypsin digested K-12 Es-
cherichia coli proteome. The purified filaments cleaved 269 peptides with a specificity
similar to that of the Trx-FliA(H)-HVR recombinant protein i.e. the protease profile
was similar to that of zinc-dependent MMPs. This is because the profile showed a pref-
erence for hydrophobic amino acids at the P1’ position. Quenched fluorometric assays
with the synthetic peptide, ALG-L showed an increase in fluorescence over time whereas
there was no apparent activity in the negative controls. An additional control was used
to ensure that the activity was not from contaminating proteases but solely from the fila-
ments. This was done by ultracentrifuging the sample containing the filaments and com-
paring the protease activity from the supernatant compared to the original. It was found
that the supernatant resulted in protease activity 12.8% of the original thus confirming
flagellar-protease specific activity as well as the absence of contaminating proteases.
Chapter 4 summarizes the evidence that the proteolytic flagellin FliA(H) forms a com-
ponent of the native polymerized flagella from the animal pathogen C.haemolyticum as
well as exhibits activity similar to that of the Trx-FliA(H)-HVR recombinant protein
and therefore MMPs. This brings us closer to understanding the biological function of
this acquired domain by flagellins of various bacterial species.
Two primary future directions underway for this project explore the questions asked in
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4.1 more deeply. The first involves the analysis of immunogold labelled FliA(H) within
the polymerized flagella of fixed Clostridium haemolyticum cells via TEM. The second
involves exploration of loss-of-function phenotypes in Clostridium haemolyticum. ClosTron
mutagenesis [90, 91] will be used to make in vivo mutants in which the glutamic acid
residue within the catalytic motif HExxH (in the HVR of FliA(H)) will be replaced with
alanine to result in loss of zinc-dependent MMP-like proteolytic activity. Repeating PICS
and QF assays with this mutant will provide strong validation for our discovery.
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Chapter 5
Additional insights into the
biological roles of proteolytic
flagellins
5.1 Summary
This thesis outlines the bioinformatics-driven discovery of the first naturally occurring
proteolytic flagella which was experimentally validated using FliA(H) from the animal
pathogen, Clostridium haemolyticum.
As outlined in chapter 3, the HVR from FliA(H), without the N and C termini was cloned
into an expression vector to investigate whether the HExxH containing HVR produces a
functional enzyme. This was done via the expression and purification of the recombi-
nant Trx-FliA(H)-HVR protein. Subsequent proteolytic profiling of this putative flag-
ellin protease with PICS revealed it cleaves peptides with a specificity similar to that of
the gluzincin family of zinc-dependent MMPs. This was confirmed by QF assays with
fluorophore-conjugated synthetic peptides. Peptides that had the hydrophobic amino
acid, leucine, in the P1’ position showed an increase in fluorescence with time. This ac-
tivity was knocked out when leucine was replaced with valine. QF assays with this flag-
ellin protease also demonstrated calcium dependent activity that was knocked out the
the presence of the metal chelator EDTA. In summary, in vitro experiments paved way
for exploring biological activity in vivo. X-ray crystallography of purified Trx-FliA(H)-
HVR to obtain a 3D structure of this protein is an important future direction that is
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currently underway. Studying the 3D protein structure relative to other protein struc-
tures in the database may give us more insight into the biochemistry and therefore the
biological function of this flagellin-associated protease.
Chapter 4 outlines the exploration of the proteolytic flagellin in vivo. Flagellar proteins
were isolated from Clostridium haemolyticum as outlined in chapter 4. Separation by
SDS-PAGE and subsequent peptide sequencing of flagellar proteins revealed that the
proteolytic flagellin FliA(H) formed the second most dominant component of the poly-
merized flagella. The structural flagellin FliC, on the other hand, was the most dom-
inant component. As revealed by immunogold TEM, the proteolytic flagellin localizes
along the filament of native polymerized flagella. Proteolytic profiling with PICS and QF
assays provided evidence for MMP-like activity from purified native flagellar filaments.
Further investigation into how this proteolytic flagellin is assembled within the polymer-
ized flagella can be obtained via immunogold TEM of whole cells with fixed flagella. Fur-
thermore, engineering mutant strains that have a modified HExxH motif within FliA(H)
may allow exploration of loss of function phenotypes in vivo. These phenotypes can be
investigated via peptidase profiling of isolated filaments from both wild-type and mutant
strains by using the PICS assay. Further investigation of phenotypes associated with the
candidate flagellin protease can be done via experimentation relative to substrates that
mimic the natural biological ECM. This may allow for the generation of more stream-
lined hypotheses regarding the broader biological function of this organism’s proteolytic
flagella.
5.2 Insights into the molecular evolution of prote-
olytic flagellin HVR
Bioinformatic analysis reveals that amongst previously uncharacterized domains in the
surface exposed flagellin HVRs, a metallopeptidase domain (M9 Peptidase) was found to
be conserved in 74 phylogenetically diverse bacterial species (Tables 5.2). These species
are mostly distributed amongst Proteobacteria and Firmicutes. The highly scattered
phylogenomic distribution of the proteolytic domain within bacterial species (Figure 5.1)
suggests a high degree of lateral gene transfer between species and phyla.
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Supplementary	 Fig.	 1.	Phylogenomic	distribution	of	 proteolytic	 flagellins	on	 the	bacterial	 tree	of	 life.	Genera	 containing	
proteolytic	 flagellin	 genes	 are	 indicated	 by	 red	 lines.	 The	 presence/absence	 pattern	 is	 highly	 scattered	 indicative	 of	
extensive	 lateral	 gene	 transfer.	 Proteolytic	 flagellins	 were	 identified	 in	 four	 major	 lineages	 (numbered	 1-4).	 The	
phylogenetic	tree	was	derived	from	Hug	et	al.	(2017).	
Figure 5.1: Phylogenomic distribution of proteolytic flagellins on the bacterial
tree of life
Genera containing proteolytic flagellin genes are indicated by red lines. The
presence/absence pattern is highly scattered indicative of extensive lateral gene
transfer. Proteolytic flagellins were identified in four major lineages (numbered
1-4). The phylogenetic tree was derived from Hug et al. 2017 (Eckhard et al.
2017, in review)
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Table	S1.	Flagellin	associated	domain	architectures	and	their	abundance	in	the	NCBI	database	as	detected	using	the	Conserved	Domain	Database.
All	flagellin	domain	architectures	analyzed	contain	Flagellin_N	and	Flagellin_C	domains
Note:	Flagellin	architectures	with	putative	enzymatic	domains	in	their	hypervariable	region	are	indicated	in	bold
Sequences Taxonomy Taxid Accessions Domain	Architecture Predicted	Protease?
21667 Bacteria 2 pfam00669~pfam00700 Flagellin_N~Flagellin_C
3286 cellular	organisms 131567 pfam00669~pfam07196~pfam00700 Flagellin_N~Flagellin_IN~Flagellin_C
715 Proteobacteria 1224 pfam00669~pfam08884~pfam00700 Flagellin_N~Flagellin_D3~Flagellin_C
417 Proteobacteria 1224 pfam00669~pfam12445~pfam00700 Flagellin_N~FliC~Flagellin_C
155 Rhizobiales 356 pfam00669~pfam07482~pfam00700 Flagellin_N~DUF1522~Flagellin_C
67 Burkholderiaceae 119060 pfam00669~pfam12613~pfam00700 Flagellin_N~FliC_SP~Flagellin_C
35 Bacteria 2 pfam00669~pfam01752~pfam00700 Flagellin_N~Peptidase_M9~Flagellin_C Y
24 Bacteria 2 pfam00669~pfam11863~pfam00700 Flagellin_N~DUF3383~Flagellin_C
21 Bacteria 2 pfam00669~cl00057~pfam00700 Flagellin_N~vWFA~Flagellin_C
17 Acinetobacter	sp.	CAG:196 1262690 pfam00669~pfam05342~pfam00700 Flagellin_N~Peptidase_M26_N~Flagellin_C Y
12 Bacteria 2 pfam00669~cl14813~pfam00700 Flagellin_N~GluZincin~Flagellin_C Y
10 Desulfovibrionales 213115 pfam00669~cl21531~pfam00700 Flagellin_N~Sialidase~Flagellin_C
10 Pseudomonas 286 pfam00669~pfam04004~pfam00700 Flagellin_N~Leo1~Flagellin_C
9 Bacteria 2 pfam00669~pfam07196~cl00160~pfam00700 Flagellin_N~Flagellin_IN~LbetaH~Flagellin_C
9 Proteobacteria 1224 pfam00669~cl14106~pfam00700 Flagellin_N~Rifin_STEVOR~Flagellin_C
7 Bacteria 2 pfam00669~cl21456~pfam00700
Flagellin_N~Periplasmic_Binding_Protein_Type
_2~Flagellin_C
7 delta/epsilon	subdivisions 68525 pfam00669~cl00160~pfam00700 Flagellin_N~LbetaH~Flagellin_C
5 Bacteria 2 pfam00669~cl21454~pfam00700 Flagellin_N~NADB_Rossmann~Flagellin_C
5 Enterobacteriaceae 543 pfam00669~cl12013~pfam00700 Flagellin_N~BAR~Flagellin_C
5 Proteobacteria 1224 pfam00669~cl19731~pfam00700 Flagellin_N~SipA~Flagellin_C
5 Proteobacteria 1224 pfam00669~cl16912~pfam00700 Flagellin_N~MDR~Flagellin_C
4 Proteus	mirabilis 584 pfam00669~cl02760~pfam00700 Flagellin_N~NEAT~Flagellin_C
4 Bacteria 2 pfam00669~pfam12211~pfam00700 Flagellin_N~LMWSLP_N~Flagellin_C
4 Vibrio 662 pfam00669~pfam07196~pfam14925~pfam00700
Flagellin_N~Flagellin_IN~HPHLAWLY~Flagellin_
C
4 Methylibium 316612 pfam00669~cl00261~pfam00700 Flagellin_N~PLPDE_III~Flagellin_C
4 Butyrivibrio 830 pfam00669~pfam06156~pfam00700 Flagellin_N~DUF972~Flagellin_C
4 Bacteria 2 pfam00669~cl15685~pfam00700 Flagellin_N~Wzt_C-like~Flagellin_C
3 Bacteria 2 pfam00669~cl07060~pfam00700 Flagellin_N~NPCBM~Flagellin_C
3 Bacteria 2 pfam00669~cl21487~pfam00700 Flagellin_N~OM_channels~Flagellin_C
3 Bacteria 2 pfam00669~pfam13861~pfam00700 Flagellin_N~FLgD_tudor~Flagellin_C
3 Gammaproteobacteria 1236 pfam00669~TIGR02597~pfam00700 Flagellin_N~TIGR02597~Flagellin_C
3 Roseburia	inulinivorans 360807 pfam00669~cl00342~pfam00700 Flagellin_N~Trp-synth-beta_II~Flagellin_C
3 Vibrio 662 pfam00669~pfam07196~cl21456~pfam00700
Flagellin_N~Flagellin_IN~Periplasmic_Binding_
Protein_Type_2~Flagellin_C
3 Clostridium	tyrobutyricum 1519 pfam00669~cl21455~pfam00700 Flagellin_N~P-loop_NTPase~Flagellin_C
3 Carnobacterium	sp.	17-4 208596 pfam00669~cl01110~pfam00700 Flagellin_N~Sdh5~Flagellin_C
3 Bacillales 1385 pfam00669~pfam04574~pfam00700 Flagellin_N~DUF592~Flagellin_C
3 Gluconobacter	oxydans 442 pfam00669~cl11960~pfam00700 Flagellin_N~Ig~Flagellin_C
2 Bacteria 2 pfam00669~pfam07559~pfam00700 Flagellin_N~FlaE~Flagellin_C
2 Bacteria 2 pfam00669~cl18945~pfam00700 Flagellin_N~AAT_I~Flagellin_C
2 Enterobacteriaceae 543 pfam00669~cl05878~pfam00700 Flagellin_N~TraK~Flagellin_C
2 Arcobacter	butzleri 28197 pfam00669~cl18951~pfam00700 Flagellin_N~Amidase~Flagellin_C
2 Chitinibacter 230666 pfam00669~cl09928~pfam00700
Flagellin_N~Molybdopterin-
Binding~Flagellin_C
2 Bacteria 2 pfam00669~cl00192~pfam00700 Flagellin_N~ribokinase_pfkB_like~Flagellin_C
2 Azoarcus	sp.	CIB 198107 pfam00669~pfam09249~pfam00700 Flagellin_N~tRNA_NucTransf2~Flagellin_C
2
delta	proteobacterium	
MLMS-1 262489
pfam00669~pfam07196~cl00160~cl02073~pfam0
0700
Flagellin_N~Flagellin_IN~LbetaH~DUF3422~Fla
gellin_C
2 Bacillus	alcalophilus 1445 pfam00669~pfam11589~pfam00700 Flagellin_N~DUF3244~Flagellin_C
2 Borreliella	lusitaniae 100177 pfam00669~pfam14796~pfam00700 Flagellin_N~AP3B1_C~Flagellin_C
2 Nitrospira	defluvii 330214 pfam00669~cl21542~pfam00700 Flagellin_N~EthD~Flagellin_C
2 Firmicutes 1239 pfam00669~cl23771~pfam00700 Flagellin_N~Big_3_4~Flagellin_C
2 Rhodopirellula 265488 pfam00669~cl10557~pfam00700 Flagellin_N~Dak1~Flagellin_C
2 Gammaproteobacteria 1236 pfam00669~cl11964~pfam00700 Flagellin_N~CYTH-like_Pase~Flagellin_C
2 Bacillus	sp.	SG-1 161544 pfam00669~cl14647~pfam00700 Flagellin_N~GH43_62_32_68~Flagellin_C
2 Bacteria 2 pfam00669~cl14876~pfam00700 Flagellin_N~Zinc_peptidase_like~Flagellin_C Y
2 Enterobacter	cloacae 550 pfam00669~cl22495~pfam00700 Flagellin_N~Gp23~Flagellin_C
2 Cellvibrio	sp.	BR 1134474 pfam00669~cl01077~pfam00700 Flagellin_N~SIMPL~Flagellin_C
2 Idiomarina	xiamenensis 1207041 pfam00669~cl00278~pfam00700 Flagellin_N~CCC1_like~Flagellin_C
2 Rhodospirillaceae 41295 pfam00669~pfam10983~pfam00700 Flagellin_N~DUF2793~Flagellin_C
1 Bdellovibrio	bacteriovorus 959 pfam00669~cl01193~pfam00700 Flagellin_N~DUF463~Flagellin_C
1 Paenibacillus	alginolyticus 59839 pfam00669~cl21457~pfam00700
Flagellin_N~TIM_phosphate_binding~Flagellin_
C
1 Nematostella	vectensis 45351 pfam00700~pfam00669 Flagellin_C~Flagellin_N
1 Lactobacillus	capillatus 480931 pfam00669~cl01389~pfam00700 Flagellin_N~Phage_sheath_1~Flagellin_C
1 Escherichia	fergusonii 564 pfam00669~cl00262~pfam00700 Flagellin_N~TroA-like~Flagellin_C
Table 5.1: Flagellin associated domain architectures and their abundance in
the NCBI database as detected using the Conserved Domain Database.
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GI Ref Name Species
738243862 WP_036199097.1 hypothetical	protein Lysinibacillus	sinduriensis	
916691384 WP_051298475.1 hypothetical	protein Marinobacterium	litorale
518372292 WP_019542499.1 hypothetical	protein Selenomonas	bovis
916573195 WP_051180286.1 hypothetical	protein Selenomonas	ruminantium
504238503 WP_014425605.1 putative	flagellin Selenomonas	ruminantium	
917028657 WP_051635369.1 hypothetical	protein Selenomonas	sp.	ND2010
916926872 WP_051533584.1 hypothetical	protein Anaerovibrio	sp.	RM50
917657302 WP_052211964.1 hypothetical	protein Anaerovibrio	lipolyticus
653148213 WP_027397410.1 hypothetical	protein Anaerovibrio	lipolyticus
507777340 EOS35535.1 hypothetical	protein C808_04738	Lachnospiraceae	bacterium	M18-1
551000896 WP_022745605.1 hypothetical	protein Dorea	sp.	5-2
507824683 EOS80891.1 hypothetical	protein C817_01227	Dorea	sp.	5-2
769144802 WP_044921500.1 hypothetical	protein Lachnospiraceae	bacterium	MA2020
910018461 WP_049973154.1 	hypothetical	protein Lachnospiraceae	bacterium	MC2017
910018462 WP_049973155.1 hypothetical	protein Lachnospiraceae	bacterium	MC2017
651905107 WP_026658295.1 hypothetical	protein Butyrivibrio	sp.	AC2005
697062782 WP_033152383.1 hypothetical	protein Pseudobutyrivibrio	ruminis
769166148 WP_044939094.1 hypothetical	protein Pseudobutyrivibrio	sp.	LB2011
651903221 WP_026657293.1 hypothetical	protein Butyrivibrio	sp.	AC2005
551017073 WP_022761310.1 flagellin Butyrivibrio	sp.	AD3002
651387362 WP_026499388.1 hypothetical	protein Butyrivibrio	sp.	WCD2001
651394250 WP_026505968.1 hypothetical	protein Butyrivibrio	sp.	NC3005
551028220 WP_022772304.1 flagellin Butyrivibrio	sp.	AE2015
916590076 WP_051197167.1 hypothetical	protein Butyrivibrio	sp.	XBB1001
490739930 WP_004602238.1 flagellin/flagellar	hook	associated	protein Eubacterium	cellulosolvens	
916920396 WP_051527108.1 hypothetical	protein Eubacterium	cellulosolvens
517856800 WP_019027008.1 hypothetical	protein Colwellia	piezophila
766745642 WP_044831744.1 hypothetical	protein Thalassomonas	actiniarum	
766760745 WP_044838529.1 hypothetical	protein Thalassomonas	viridans	
654652764 WP_028113749.1 hypothetical	protein Ferrimonas	kyonanensis
916608721 WP_051215812.1 hypothetical	protein Ferrimonas	futtsuensis
497523220 WP_009837418.1 flagellar	protein Pseudoalteromonas	tunicata	
654852782 WP_028305148.1 hypothetical	protein Oceanospirillum	maris
654847818 WP_028300311.1 hypothetical	protein Oceanospirillum	beijerinckii
518442882 WP_019613089.1 hypothetical	protein Psychromonas	ossibalaenae
655481215 WP_028863050.1 hypothetical	protein Psychromonas	aquimarina
917474576 WP_052080993.1 hypothetical	protein Pseudomonas	sp.	ML96
917193838 WP_051800550.1 hypothetical	protein Pseudomonas	oleovorans
1057533868 WP_068829844.1 hypothetical	protein Pseudomonas	sp.	BMS12
759519778 WP_043240123.1 hypothetical	protein Pseudomonas	alcaligenes
544803667 WP_021220822.1 hypothetical	protein Pseudomonas	alcaligenes	
919350262 WP_052807587.1 hypothetical	protein Pseudomonas	sp.	FeS53a
758832821 KIV71406.1 Flagellin	protein	FlaB Pseudomonas	sp.	FeS53a
495134114 WP_007858923.1 flagellin Acidovorax	sp.	CF316	
950225299 WP_057269442.1 flagellin Acidovorax	sp.	Root219	
948088328 WP_056747048.1 flagellin Acidovorax	sp.	Root568	
947398799 WP_056064769.1 flagellin Acidovorax	sp.	Root402	
1023918667 WP_063462804.1 flagellin Acidovorax	sp.	GW101-3H11	
498146157 WP_010460313.1 flagellin Acidovorax	radicis
950228284 WP_057272374.1 flagellin Acidovorax	sp.	Root267	
950175389 WP_057223076.1 flagellin Acidovorax	sp.	Root275	
493342448 WP_006299301.1 flagellin Hylemonella	gracilis	
737635795 WP_035605832.1 flagellin Hylemonella	gracilis	
1054768843 WP_066532860.1 flagellin Comamonas	terrigena
759662642 WP_043380247.1 flagellin Comamonas	aquatica	
835203907 WP_047395168.1 hypothetical	protein Chitinibacter	sp.	ZOR0017
654999239 WP_028448441.1 hypothetical	protein Chitinibacter	tainanensis
517221226 WP_018410044.1 hypothetical	protein Methyloversatilis	thermotolerans
1059956041 WP_069037803.1 hypothetical	protein Methyloversatilis	sp.	RAC08
1059488308 AOF81425.1 hypothetical	protein	BSY238_565 Methyloversatilis	sp.	RAC08
522143982 WP_020655191.1 hypothetical	protein Massilia	niastensis
916699479 WP_051306570.1 hypothetical	protein Massilia	alkalitolerans
947778910 WP_056440654.1 hypothetical	protein Massilia	sp.	Root335	
738284338 WP_036238512.1 hypothetical	protein Massilia	sp.	JS1662	
947464650 WP_056129008.1 MULTISPECIES:	hypothetical	protein Massilia	
500090247 WP_011766260.1 flagellin Azoarcus	sp.	BH72	
1043078958 WP_065340783.1 hypothetical	protein Azoarcus	olearius	
847184073 WP_047967967.1 hypothetical	protein Vogesella	sp.	EB	
938316768 WP_054620994.1 hypothetical	protein Rhodocyclaceae	bacterium	Paddy-1
737307010 WP_035289894.1 hypothetical	protein Clostridium	sp.	KNHs214
746179135 WP_039238750.1 hypothetical	protein Clostridium	novyi	
746201658 WP_039258875.1 hypothetical	protein Clostridium	botulinum	
746169334 WP_039229452.1 hypothetical	protein Clostridium	haemolyticum	
19910973 BAB87738.1 flagellin	protein	FliA(H) Clostridium	haemolyticum
746189539 WP_039247767.1 hypothetical	protein Clostridium	novyi	
737261571 WP_035245515.1 hypothetical	protein Desulfobulbus	mediterraneus
492846401 WP_006000355.1 flagellin-like Desulfuromonas	acetoxidans	
550893434 WP_022654199.1 flagellin Aquaspirillum	serpens
1062631149 WP_069313537.1 hypothetical	protein Piscirickettsia	sp.	Y2	
737346898 WP_035329181.1 hypothetical	protein Bacillus	firmus	
766666229 WP_044826104.1 hypothetical	protein Clostridium	aceticum	
738759210 WP_036652630.1 hypothetical	protein Paenibacillus	wynnii	
504121263 WP_014355249.1 flagellin Acetobacterium	woodii	
503951982 WP_014185976.1 flagellin/flagellar	hook	associated	protein Desulfosporosinus	orientis	
505207458 WP_015394560.1 flagellin Clostridium	saccharoperbutylacetonicum	
1011282853 WP_062200331.1 hypothetical	protein Bacillaceae	bacterium	mt8
Table	S2.	Eighty-six	predicted	"proteolytic	flagellins"	identified	in	the	NCBI	database.	All	possess	a	putative	gluzincin-family	
metallopeptidase	domain	in	their	hypervariable	region.
Table 5.2: Predicted ”proteolytic flagellins” identified in the NCBI database.
The figure shows the 86 predicted proteolytic flagellins idenified in the NCBI
database. All possess a putative gluzincin-family metallopeptidase domain in their
hypervariable region.
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Considering that this domain was predicted to have collagenase-like activity, the origin
of this domain may have been a Clostridia species that natively use collagenases for nu-
trient acquisition. A collagenase-like domain may have been acquiried by the flagellin
HVR via intragenic recombination and then undergone a shift in substrate specificity.
As suggested earlier in the thesis, the double-glycine motif is absent from the HVR-
associated protease, which is a key determinant of substrate specificity of Clostridial
collagenases. Clostridia species as a source of the original gluzincin proteolytic flagellin
gene is further supported by the fact that the proteolytic flagellin family clusters sepa-
rately from all other gluzincin proteases. After initial acquisition, this domain may have
spread to other species by lateral gene transfer (Figure 5.2). Examples of proteolytic
flagellin gene insertions are directly evident by comparative analysis of gene clusters con-
taining the proteolytic flagellin gene. For instance, in Comamonas aquatica DA1877, a
single proteolytic flagellin gene has been inserted within a conserved gene cluster present
in other Comamonadaceae (Figure 5.2). To gain insights into the broader functions of
the proteolytic flagellin family, the functions of neighbouring genes were examined. In-
terestingly, most gene clusters containing a proteolytic flagellin gene also include other
flagellar genes, especially within Clostridium and several specific lineages (Figure 5.2).
These proteolytic flagellins are therefore likely to be co-regulated with, and components
of, the flagellar machinery. In other genomes, genes flanking the proteolytic flagellin in-
clude other peptidases, membrane proteins, ABC transporters, and in a few cases trans-
posase or transposon-related sequences which may reflect a mobile mechanism of transfer
(Figure 5.2).
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Figure 5.2: Genomic context of proteolytic flagellin gene
Genomic context surrounding the proteolytic flagellin gene in 40 genomes (left)
and evidence for a proteolytic flagellin gene insertion into conserved
Comamonadaceae gene cluster (right). The 40 gene clusters are ordered into ten
clusters based on a phylogeny of the flagellin protease domain (Eckhard et al.
2017, in review)
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5.3 Insights into the biological function of proteolytic
flagellins
The presence of proteolytic flagella in the animal pathogen,Clostridium haemolyticum,
has several biological implications. Protease activity from a flagella of an organism bur-
rowing through the ECM may have a much wider range than a comparable secreted pro-
tease. Additionally, considering that flagellated bacteria existed before their eukaryotic
hosts, it suggests that flagella didn’t exist as virulent organelles, but instead evolved to
play pivotal roles in various facets of pathogenesis [22]. These roles have been outlined
in 1.2.2.To speculate further, the expression and regulation of this protease could be cou-
pled to one of the many signals utilized by bacteria e.g. chemical gradients for chemo-
taxis that further assists roles such as host colonization. Other examples include, alter-
ation of flagellins for host evasion. The numerous possible roles of this flagellin HVR-
associated protease has been highlighted in Figure 5.3. Another important consideration
is that these putative proteases are encoded within approximately 5-10% of surface ex-
posed HVR of flagellin monomers and approximately 20,000 of them assemble to form a
flagellar filament. This means that each flagellar filament of Clostridium haemolyticum
may have about one to two thousand active sites. This may be advantageous for an an-
imal pathogen such as this one, because it may be capable of penetrating deeper tissue
structures. The modularity of bacterial flagellin has made it an ideal candidate for engi-
neering in vitro and has been described in 1.3. Considering that this has become avail-
able to synthetic biologists, it seems viable for evolution to favour selection of protease
domains within the HVR of bacterial flagellins.
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Figure 5.3: Hypothesized function of the flagellin-HVR associated protease
Proteolytic flagellins may play a role in various facets of pathogenesis. It may
assist in finding favourable target sites and/or dispersal, biofilm formation and/or
host evasion. This figure is modified from [22].
5.4 Conclusion
As mentioned above, the protease domain was found to be conserved in various species
amongst which is the animal pathogen, Clostridium botulinum C/D str. DC5 as well as
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avid biofilm former, Pseudoaltermonas tunicata. The phylogenetic diversity is indicative
of lateral gene transfer to be the mechanism that has allowed the protease domain to
spread. To discover the biological function of this HVR-associated proteolytic domain
may require studying its role in other species as well. Experimental characterization of
the flagellin variant in Pseudoalteromonas tunicata is currently underway in Dr. Andrew
Doxey’s laboratory. The domain may confer broad-spectrum protease activity which
may assist different species for different functions. While it may be helping Clostridium
haemolyticum to burrow through the ECM, it may be helping Pseudoalteromonas tuni-
cata in being efficient in the formation of multi-species biofilms.
To conclude, this thesis summarizes evidence for the flagellin FliA(H) from Clostridium
haemolyticum to be catalytically active. The MMP-like activity has been shown both in
vitro and in vivo. This discovery is the first instance of a naturally-occurring HVR asso-
ciated protease and may have evolved to play vital roles in various flagellated bacteria.
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Appendix A
A.1 Molecular Biology
1. Luria-Bertani (LB) Medium, For 1 Litre:
• 10g Bacto-tryptone
• 2g Yeast Extract
• 10g NaCl
2. LB agar
• LB with 15g agar
All solutions were autoclaved before use
A.2 Protein purification
1. Lysis Buffer, For 1 Litre:
• 25 mM HEPES (5.96g)
• 300 mM NaCl (17.6g)
• 10 mM Imidazole (0.68g)
• 10% Glycerol (100g) pH adjusted to 7.5
2. Elution buffer, for 100 mL:
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• 25 mM HEPES (0.596g)
• 300 mM Imidazole (2.04g) pH adjusted to 7.5
3. 25 mM HEPES buffer, for 1 Litre:
• 5.96g HEPES pH adjusted to 7.5
4. 750 mM imidazole buffer, for 1 Litre:
• 51.06g Imidazole
5. 1M IPTG, for 10 mL:
• 2.383g IPTG filter sterilized and store at -20◦C
A.3 Western Blotting
1. 10X Tris buffered Saline stock solution, for 1 Litre:
• 24g Tris Base
• 88g NaCl pH adjusted to 7.6
2. TBS-T Solution, for 1 Litre:
• 1X TBS solution
• 0.1% Tween 20
3. Blocking buffer
• 5% skim milk in 1X TBS-T
4. Wash buffer
• 2% skim milk in 1XTBS-T
81
A.4 Immunogold TEM
1. 10X Phosphate Buffered Saline stock solution (Fisher BioreagentsTM)
2. Blocking buffer
• 1X PBS
• 0.1% Triton X
• 1% BSA
3. Wash buffer
• 1X PBS
• 0.8% BSA
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